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7ABSTRACT
Sipponen, Arno.  Coniferous resin salve, ancient and effective treatment 
  for chronic wounds - laboratory and clinical studies 
Department of Orthopedics and Traumatology, University of Helsinki, Helsinki, 
Finland and Päijät-Häme Central Hospital, Lahti, Finland. 
Natural coniferous resins and other terpenic wood extracts have been raw materials 
for various products in industry, and have been used as traditional medicines in 
Finland for hundreds of years, particularly as a home-made salve for skin wounds 
and infections. Due to the author´s own positive empirical experiences of natural 
coniferous resin salve in wound care, the present “resin-project” was set up in 
order to investigate (1) the antimicrobial properties of the resin and resin salve 
by microbiological laboratory techniques, and to study (2) the efficacy, feasibility 
and safety of the resin salve for wound care in objective clinical trials. The thesis 
comprises four microbiological investigations and two clinical trials.
Microbiological studies with an agar diffusion test and with the European Phar-
macopoeia challenge test gave somewhat controversial results indicating that the 
water solubility of resin and resin salve may affect the assay results. The studies 
showed that coniferous resin and resin salve were strongly antimicrobial against a 
wide spectrum of both Gram-positive and Gram-negative bacteria, including the 
methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant 
enterococcus (VRE). The resin was, in addition, antifungal against the most com-
mon dermatophytes, and against the Candida albicans yeast. The antibacterial 
action of resin was observed to result from destruction of the bacterial cell wall 
and cell membrane structures. Microbes, both bacteria and fungi, exposed to resin 
or resin salve, showed thickening of the cell walls. The cells formed aggregations, 
showed arrested mitoses, and were finally destroyed according to the observations 
in scanning and transmission electron microscopy. In electrophysiological experi-
ments with Staphylococcus aureus, the exposure of the micro-organisms to resin 
and resin acid (abietic acid) caused dissipation of the cell membrane potential and 
changed the branching of fatty acids in the cell walls. The observed changes were 
concluded to indicate that the coniferous resin influences the bacterial cell survival 
via damage to cell membrane functions.
In tests on safety aspects, the coniferous spruce resin or resin salve were not muta-
genic in Ames tests. In skin irritation tests in rabbits (ISO 10993-10:2010 standard), 
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the resin salve containing purified coniferous resin 10% (w/w) was “negligibly” 
irritating. In in vitro cytotoxicity tests (EN ISO 10993-5:2009 and USP<87>) with 
mouse fibroblasts in HAM F12 culture medium the salve was markedly cytotoxic 
but slightly cytotoxic if diluted (1+3) with fresh culture medium.
In analyses with gas-liquid chromatography (GLC) and mass spectrometry, the 
acetone extracts of both pure spruce resin and resin salve contained coumaric acid, 
a group of diverse resin acids and lignans. All these compounds are potentially 
biologically active and were calculated to occur in total in purified spruce “callus” 
resin at a concentration of 300 mg/g of resin (w/w) and 30 mg/g (w/w) of the 10% 
resin salve, on average.
One of the clinical trials is a randomized, prospective investigation where the efficacy 
of resin salve treatment for 6 months was compared to the efficacy of hydrofiber 
dressings (with or without silver) in 37 patients with severe, grade II-IV, pressure 
ulcers. In this trial the resin salve treatment was, in both per protocol and ITT 
(intention-to-treat) analysis, significantly more effective (P=0.003) in improving 
ulcer healing (regarding both the rate of healing per patient (N=23) or per ulcers 
(N=29)) than the control treatment. All pressure ulcers in all compliant patients 
(per protocol analysis) in the resin group healed except for one ulcer in one patient 
(94% (95%CI:84–100%)) whereas less than half (36% (8-65%)) of the ulcers healed 
in the control group. Resin salve improved the ulcer healing independent of whet-
her the ulcer was infected or not. The other clinical trial was an observational and 
prospective study on efficacy and feasibility of the resin salve treatment in chronic 
(complicated) surgical wounds in a cohort of 23 patients. In all 23 patients, the 
wound healed in 43±24 days on average without any draw-backs. In multivariate 
analysis, the length of the wound was an independent and significant predictor 
of the healing time. In resin salve therapy, the wounds progressively healed (re-
epithelialized) at 2 mm per day on average. In the clinical trials, including a total 
of 45 compliant patients, one patient (2%; 95%CI:0-5%) had an allergic reaction 
(allergic contact dermatitis). No other complications or side effects were observed. 
In calculations of direct costs, the expenses of the pharmaceutical materials were 
1.2 € ±0.5 € per day on average among the patients treated with resin salve.
Descriptions of terms commonly used in the present paper are presented in Ap-
pendix I.
Keywords: Resin, rosin, Norway spruce, microbiology, pressure ulcer, wound 
healing, hydrofiber dressing, chronic surgical wound, surgical site infection, wound 
infection, cost analyses.
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1. INTRODUCTION
Treatment of chronic wounds is difficult and long-lasting. There are hundreds of 
topical treatment options available on the market with largely unproven clinical 
efficacy. Aging of the population results in higher and higher prevalence of chronic 
wounds and leads to increasing use of topical wound care products. Modern dress-
ings do not always lead to satisfactory wound healing, which makes further research 
on wound treatment options including old forgotten treatment options used in folk-
medicine relevant. Resin salve has been used for centuries in traditional medicine. 
The resin study project was set up owing to encouraging personal clinical experience 
with resin salve treatment in patients with severe pressure ulcer (Sipponen et al. 
2003, Sipponen et al. 2007). The aim of the project was to investigate the efficacy 
and the mechanisms of action of coniferous resin and resin salve in the treatment 
and healing of skin wounds and ulcers.  
1.1 MEDICAL USE OF RESIN IN THE PAST
The first reports of using resins or rosins in medicine are from the antiquity. Resins 
have been used for nearly every kind of human disorder and disease (Langenheim 
2003). In mummification, the Egyptians first used simple linen bandages and plas-
ter but began to use resin-impregnated linen bandages during the 11th dynasty, 
4000 years ago (Proefke et al. 2008). As the technologies improved, the mummies 
were dried with natron and even filled with heavily resin-soaked linen, obviously 
to improve the preservation of the body and to inhibit the insects and microbes 
destroying the tissues (Dawson 1927, Ancient Egypt 1999, Dunn 2011). 
First medical publication of the use of coniferous resin in medical practice in 
Finland is from 1578. Swedish physician Benedictus Olai wrote about natural resin 
in treatment of old leg wounds in the first medical textbook of the Swedish kingdom 
as follows: “…take wax and white spruce resin, both 2 pellets, rams tallow 2 pellets, 
ship pitch, and olive oil, both 6 pellets…keep in glass container.  The wound has 
to be washed three times a day with sweet wine, and then spread with the above 
mentioned salve” (Olai 1578). 
Elias Lönnrot (1802-1884) was a Finnish physician, botanist and philologist. 
In his publication on Finnish botany, in the Flora Fennica from 1866, Elias Lönn-
rot wrote about coniferous resin as follows: “when the tree rind is wounded in the 
summer, a resin-like liquid streams out, which will solidify to thick terpene that 
can be used externally as a detergent and wound curative” (Lönnrot et al. 1866). 
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Beside the use for medical purposes, resin and rosin have been used in vari-
ous non-medical applications (Langenheim 2003). Such application range from 
religious purposes to production of incenses, and includes even the ship industry. 
Rosin has been a raw material for various products in the chemical industry, the 
end products being, for example, paints, lacquers, solvents, printing inks, chewing 
gums, spices and perfumes, soaps and other items of personal hygiene (Metsälä 
2001). Pine resin has been an important commodity at least since biblical times, 
as attested by the story of Noah receiving instructions from God to “cover the ark 
inside and out with pitch” (Bible approx. 1000 BCE). 
Salves manufactured from the Norway spruce (Picea abies) have been utilized 
for centuries in folk-medicine, at least in the northern part of Finland and Sweden. 
Traditionally the resin salve was prepared by boiling the resin with butter or animal 
fat. The resulting salve was used, and is still in use, as a home-made remedy for 
wounds, skin infections and abscesses. A typical indication for the resin salve treat-
ment was, for example, the “resin suction” in cases where a foreign body had to be 
removed from the skin (e.g.; wooden splinter) (Timo Kyrö personal communication 
2006, Pakkanen et al. 2011). In practice, the resin salve was used occasionally in 
primary care even by the authorized physicians in treatment of different kinds of 
skin wounds, in northern Finland in particular. 
In the beginning of millennium, the author and his colleagues had positive ex-
periences from some sporadic patient cases treated with the traditional resin salve 
in Kolari health care center, Finnish Lapland, suggesting that the resin salve is an 
effective and a well tolerated treatment option in skin wounds and ulcers (Sipponen 
et al. 2003, Sipponen et al. 2007). Therefore, the present “Resin Project” was set 
up to study objectively the effectiveness and the mechanisms of resin salve and 
natural coniferous resins in wound care. 
The recipes and recommendations published by Benedictus Olai in 1578 or by 
Elias Lönnrot in the 19th century are obviously the only few publications of resin 
salve treatment for wound care before 2003. Although resin salve has been used in 
folk medicine for centuries, scientific and objective studies on its clinical efficiency 
in human medicine do not seem to exist. No scientific papers in English can be 
found in the PUBMED database before 2003 by the words “resin and skin”, “resin 
and skin wound”, or “coniferous resin and skin ulcer”. 
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1.2 CONIFEROUS RESIN 
1.2.1   BIOLOgy
The conifers (e.g., pine, spruce, balsam, fir, etc.) synthesize resin (oleoresin) which 
is composed of pure resin acids mixed with various volatile and nonvolatile terpenes 
(Langenheim 2003, Keeling et al. 2006, Zulak et al. 2010). This resin is yellowish 
and liquid and can be trickled by artificially wounding of the tree trunk (Nagy et al. 
2000). Some distilled fractions of the wood extracts (e.g., pine oil, tall oil) of conif-
erous trees are called rosins and contain only resin acids in varying ratios, being, 
thereby, largely similar in composition to the natural heartwood resin (oleoresin) 
(Holmbom et al. 2008, Zulak et al. 2010). By heating and pyrolysis (e.g., in tar 
kilns) the resins form tars, a process during which carcinogenic compounds are 
also formed.
In biology, the coniferous resin has been mainly studied by the wood physi-
ologists and chemists. Coniferous resins are divided into physiological and non-
physiological resins (pitch). The physiological one (oleoresin) appears mainly in 
resin canals of the heartwood and knots (Langenheim 2003). The heartwood resin 
(oleoresin) is a mixture of resin acids, other terpenes and fatty acids. In case of 
wounding of the tree rind, the heartwood resin, oleoresin, is exuded into the sap-
wood and further onto the tree surface (Holmbom et al. 2008, Zulak et al. 2010). 
Exudation of the oleoresin starts 3―4 weeks after the wounding. With time and 
evaporation of the volatile terpenic compounds, the oleoresin on the wound sur-
face will be mixed with secretions and ingredients from the cells in wood sap and 
surface, resulting in knot-like masses composed of the sc. non-physiological resin. 
This non-physiological “callus” resin occurs as nodular swellings on the rim of the 
wound (Holmbom et al. 2008).
On the tree trunk, the initially liquid physiological resin (oleoresin) will be hard-
ened with time resulting in multicolored, dark and semisolid material (Fig. 1). This 
material, “callus” resin, is mechanically removable, for example, by knife or axe. 
The callus resin of Norway spruce (Picea abies) has been the typical raw material 
for the home-made salves and is also the raw material of the resin used in the pre-
sent study, or of salves industrially prepared and manufactured from the natural 
coniferous resin.
16
INTRODUCTION
All coniferous trees synthesize and secrete resin that vary somewhat in content 
and type of resin acids (Holmbom et al. 2008). Resin is easily drawn off in liquid 
form from the trunk of pines, for example, whereas the solid or semisolid masses 
of the multicolored resin swellings on the tree trunk (“callus resin”) are formed in 
the spruce, and are the natural source of the resin.
Fungal and bacterial infections cause disease in the conifers, against which the 
trees form and secrete resins, obviously as a defense (Byun-McKay et al. 2006, Zu-
lak et al. 2010). The conifers have likely evolved the terpene-based resin secretions 
to deter insect pests and to prevent microbial contact and invasion, a mechanism 
that resembles the sticking-plaster in prevention of the infections in human skin 
wounds (Trapp et al. 2001, Franceschi et al. 2005). As hydrophobic compounds, 
resin may also inhibit the influx of water and protect the tree from dehydration 
(Holmbom et al. 2008). 
Figure 1 norway spruce (Picea abies) is a common conifer in the taiga zone, also known as the boreal 
forest, which is the world’s largest terrestrial biome. in north America it occupies most of inland canada and 
Alaska as well as parts of the extreme northern continental United states. it also covers most of sweden, 
Finland, norway, russia (siberia in particular), northern Kazakhstan, northern mongolia, and northern Japan 
(Hokkaido). the “callus resin” (insert) is formed as masses on the surface of the conifer trunk if the tree 
surface is wounded. callus resin is multicolored, solid or semisolid and is composed of various ingredients 
synthesized and secreted by the heartwood and sapwood cells.
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1.2.2 CHEMICAL COMPOSITION 
The chemical composition of plant resins depends on the definitions used and the 
source of the resin. The resin, in general terms, is a liquid hydrocarbon secretion 
of many plants, and is mainly composed of volatile and nonvolatile terpenes and 
essential oils (Langenheim 2003). Some resins, particularly in conifers, contain a 
mixture of diterpenic, organic carboxylic acids, called resin acids, in high quantity 
(Kimland 1972, Holmbom et al. 2008). The components of resin can be separated 
by fractional distillation. Distillation of the physiological resin (oleoresin) from wood 
extracts results in formation of rosins, which are mixtures of various resin acids 
(Zulak et al. 2010). The rosins and resins are solid at room temperature. The oleo-
resins that contain benzoic acid or cinnamic acids are called balsams. 
The resin acids in resins and rosins are diterpenic, tricyclic organic acids and are 
classified as abietic acid or pimaric acid types (Langenheim 2003, Zulak et al. 2010). 
These diterpenic resin acids are nonvolatile and are one of the major components 
of the solid spruce callus resin. Abietic acid, dehydroabietic acid, hydroxydehydro-
abietic acid and neoabietic acid are examples of common resin acids of the abietic 
type. Pimaric and isopimaric acids are the corresponding examples of acids of the 
pimaric type. The resin acids are soluble in alcohol, DMSO and various organic sol-
vents but are poorly water soluble, excepting some solubility of the dehydroabietic 
acid and hydroxydehydroabietic acids (Peng et al. 2000, unpublished preliminary 
studys). At room temperature the resin acids are solid (melting point above 150oC).
1.2.3 ANTIMICROBIAL PROPERTIES 
The scientific literature on the microbiology of plant extracts is large. Many terpenes 
and terpenoids have been shown to be antimicrobial against bacteria, fungi, and 
even against viruses or protozoa (Cowan 1999, Peng et al. 2000). The microbiology 
of the resin acids of coniferous origin is relatively extensive but largely targeted on 
studies on bioaugmentation of bacteria and fungi for removal of the resin acids from 
pulp mill effluents (Liss et al. 1997, Mohn et al. 1999, Yu et al. 2001, Kallioinen et 
al. 2003, Kostamo et al. 2003). Resin acids and rosin in high concentrations are 
toxic to aquatic organisms, and may impair the proper function of paper machines 
(Yu et al. 2001). In addition, the isolation of microbes of genera Sphingomonas, 
Zoogloea, Raistonia, Burkholderia, Pseudomonas and Mycobacterium may grow 
on and utilize resin acids (Mohn et al. 1999, Yu et al. 2001).
The antibacterial and antifungal properties of the resin acids are examined by 
biologists and wood microbiologists with ordinary microbiological laboratory tech-
niques and also by using pine wood blocks and spruce wood chips as culture media 
(Mohn et al. 1999, Savluchinske-Feio et al. 1999, Gigante et al. 2002, Kallioinen et 
al. 2003, Savluchinske-Feio et al. 2007). 
18
INTRODUCTION
The antimicrobial activity of the resin acids, even against multiresistant bacte-
ria, is documented in several earlier papers in the literature in English (Smith et 
al. 2005, Savluchienske-Feio et al. 2006, González et al. 2009), suggesting that the 
resin acids are strongly antimicrobial. Also, the literature on applications of the tech-
nical rosins in dentistry is relatively large and indicates that the rosins intermixed 
with dental adhesives and cements are antimicrobial as well (Herrera et al. 2000). 
Microbiological examinations specifically on the natural spruce callus resin, or 
on corresponding resin salves, do not exist, however. No publications can be found 
in the PUBMED database with key words “resin and antibacterial property” before 
2008. On the other hand, there are, before and after 2008, studies in the medical 
literature on the antibacterial properties of purified resin acids and of Portuguese 
rosin (Söderberg et al. 1990, Söderberg et al. 1991, Johansson et al. 1995). These 
studies apply usual microbiological techniques and inevitably demonstrate a clear 
antimicrobial activity of the resin acids against bacteria, against the Gram-positive 
bacteria in particular. The investigations suggested that obviously dehydroabietic acid 
has the most potent antibacterial activity (Söderberg et al. 1990, Wang et al. 2012). 
1.3 CHRONIC WOUNDS AND WOUND HEALINg
Tissue repair is a necessity for life and well-being. The proper healing of skin wounds 
is an example of this well-being. Skin wounds are classified as acute and chronic. 
An acute wound is defined as injury of the skin, which heals in a predictable time 
through normal wound healing process (Diegelmann et al. 2004). A chronic wound 
is defined as a wound that heals within weeks or months, whereby the healing is 
delayed or cannot be predicted (Broderick 2009). Various mechanisms and factors 
may impair the normal, healing process, resulting in a chronic wound (Broughton 
et al. 2006). 
Chronic skin wounds are extremely common throughout the world. It is esti-
mated that 70% of all chronic wounds in Finland are pressure ulcers, venous leg 
ulcers or diabetic wounds (Eriksson et al. 1999). The crude prevalence of leg ulcers in 
adult populations varies in different studies in Finland and other countries between 
0.1―0.9%, and the prevalence of pressure ulcers in geriatric wards is estimated to 
be around 22% (Eriksson et al. 1999, Woodbury et al. 2004). It is assumed that 1% 
of people in developed countries will suffer from a chronic leg ulcer during their life 
(O`Meara et al. 2010). The prevalence of active leg ulceration in Europe is reported 
to be 0.1―0.5% in the adult population on average, the prevalence rising even up to 
8.3% in age groups over 85 years (Callam et al. 1985, Nelzen et al. 1991, Nelzen et 
al. 1996, Moffatt et al. 2004). Approximately 70% of all leg ulcers are considered to 
be related to venous hypertension and venous insufficiency (O`Meara et al. 2009). 
More rare types of skin ulcers are malignant wounds, or wounds due to vasculitis.
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Costs of wound care are high in general. It is estimated in United States that 
the treatment of chronic wounds costs several billion dollars, annually (Fonder 
et al. 2008). In the UK, annual costs from pressure ulcers alone are estimated 
to be 2.5 billion €, corresponding to 2.6% of the National Health Service budget 
(Franks 2007). Unorganized treatment of chronic wounds in the district of Helsinki 
University Hospital (appr. 1 million inhabitants) cost 20 – 40 million € per year 
(Lepäntalo et al. 2009). 
1.3.1 PRESSURE ULCERS (BED SORE)
Pressure ulcers (“bed sores”) result from ischemia of skin tissue due to pressure over 
the bony prominences. The most important predisposing factors are immobilization, 
malnutrition and ischemia, and a patient´s senility (Lyder 2003, Thomas 2006, 
Stechmiller et al. 2008, Ontario Health Technology Advisory Committee Meta-
analysis 2009, White-Chu et al. 2011). The prevalence of pressure ulcers varies from 
0.4% to 38% among patients in acute care units, from 2.2% to 29% in those in long-
term care units, and from 0% to 17% among geriatric patients in homecare (Lyder 
2003, Reddy et al. 2006, Thomas 2006, Franks 2007). The treatment of pressure 
ulcers is difficult, laborious, and expensive, and the ulcers are often colonized with 
bacteria (Kontiainen et al. 1988, Lohi et al. 2010). It is estimated that the care of 
chronic wounds in the USA, among which the pressure ulcer is a major disease, 
costs 6―15 billion US dollars annually (Markova et al. 2012). Correspondingly, the 
annual wound care costs in Denmark, a country with similar population to that of 
Finland, are estimated to be around 100 million € (Hjort et al. 2010). 
Avoidance of the risk factors and preservation of the skin integrity are the main 
targets to reduce the ulcer risk (Stechmiller et al. 2008, Ontario Health Technology 
Advisory Committee Meta-analysis 2009, White-Chu et al. 2011). The main treat-
ment principles of the ulcer are the reduction of pressure on the bone prominences, 
prevention of friction or shear forces, in addition to effective local ulcer care, surgical 
debridement of necrotic tissue, management of bacterial contamination or infec-
tion, and optimization of the patient’s nutritional status (Moore et al. 2005, Reddy 
et al. 2006, Ontario Health Technology Advisory Committee Meta-analysis 2009). 
Due to poor overall health, patients with severe pressure ulcers are often outside 
the surgical treatment options (plastic surgery), and topical ulcer care remains the 
prime approach in the management of these patients. 
For topical management of pressure ulcers, there are hundreds of different prod-
ucts on the market with varying clinical effectiveness or applicability, and with high 
variance in price (Iivanainen et al. 2011). Generally the selection of the dressing 
should be based on the nature of the tissue in the ulcer bed. There is some evidence 
of clinical effectiveness (supported by direct or indirect evidence from properly de-
signed clinical series on pressure ulcers in humans providing statistical results that 
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support recommendations) for some commercially available products (European 
Pressure Ulcer Advisory Panel 2009). 
1.3.2 THE CHRONIC SURgICAL WOUND 
If the skin wound after surgical operation is not primarily healed in 2―3 weeks, the 
wound is considered chronic, and heals by secondary intention (Hirschmann 2011). 
In clinical practice in Finland and elsewhere, approximately 4% of surgical 
wounds will be infected. Staphylococci are the most prevalent cause, and the in-
fection results ultimately in chronic complicated surgical wound (Haley et al. 1985, 
Haukipuro 1996). Other well-known risk factors of the chronic complicated wounds 
are the use of corticosteroids or other immunosuppressive medicaments, systemic 
diseases like diabetes mellitus, and smoking (Hachenberg et al. 2010). Prevention 
of chronic surgical wounds requires the recognition and the correction of these 
risk factors. The treatment options include adequate topical wound care, surgical 
debridement of the necrotic tissue, and the removal of visible foreign materials 
(e.g., osteosynthesis material), management of the infection, and optimization of 
the nutritional status (Haukipuro 1996, Gottrup 2008). In topical treatment, how-
ever, no objective and high quality studies on effectiveness exist regarding the great 
majority of available products (Vermeulen et al. 2004). 
1.3.3    NORMAL WOUND HEALINg
Normal wound healing is a complex phenomenon that includes the up-regulation 
and down-regulation of various cellular and molecular mechanisms, such as phago-
cytosis, chemotaxis and mitogenesis of many cell types, collagen synthesis, and 
the synthesis of various matrix components in carefully controlled cascades that 
correlate with the appearance of distinct clinical stages, e.g., hemostasis, inflam-
mation, proliferation and remodeling (Clark 1996, Broughton et al. 2006, Velnar 
et al. 2009). The healing stages involve interactions of many regulatory pathways, 
and include participation of various tissue and cell growth factors, cytokines and 
hormones, and may be summarized as follows based on several references (Winter 
1962, Levenson et al. 1965, Leibovich et al. 1975, Kurkinen et al. 1980, Grinnell et al. 
1981, Clark et al. 1982, Clark 1991, Clark 1993, Grinnell 1994, Slavin 1996, Herrick 
et al. 1997, Witte et al. 1997, Agren et al. 1998, Nwomeh et al. 1999, Tonnesen et 
al. 2000, Armstrong et al. 2002, Cross et al. 2003, Gabbiani 2003, Desmouliere 
2005, Broughton et al. 2006, Hinz 2007, Barrientos et al. 2008, Kota et al. 2012): 
Stage of hemostasis: Skin injury results in damage to blood vessels and in ex-
travasation of blood into the tissues. After injury, the exposed skin collagen comes 
into contact with blood, promoting platelet aggregation and activation of chemotactic 
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factors. Vasoconstriction and coagulation will limit the blood loss and lead to clot 
formation and platelet aggregation. The clot, composed of fibrin, fibronectin, vitron-
ectin, von Willebrand factor and thrombospondin, forms the primary matrix for the 
migration of cells in the injured tissue area. The platelets are trapped and promote 
the inflammatory response. The granules of the platelets contain growth factors, 
such as platelet-derived growth factor (PDGF), insulin-like growth factor-1 (IGF-
1), epidermal growth factor (EGF), and transforming growth factor-beta (TGF-β), 
which start the wound healing cascades by attracting and by activating fibroblasts, 
endothelial cells and macrophages. The vasoactive serotonin in platelets increases 
the microvascular permeability which results in edema and in exudation of fluid 
into the extravascular space. 
Stage of early inflammation (24―48h). The early inflammatory phase in wound 
healing begins with the activation of the complement cascade. Complement compo-
nents, like C5a, promote infiltration of the polymorphonuclear leucocytes (PMNLs). 
The PMNLs adhere to endothelial cells and move through the vessel wall (diapede-
sis). The PMNLs are capable of phagocytosis of bacteria and foreign materials and 
hence prevent infection but may otherwise contribute little to the normal wound 
healing processes and debridement. The PMNLs kill micro-organisms by releas-
ing degrading enzymes, oxygen-derived free radicals and reactive nitrogen species. 
This phase of wound healing ceases within a few days, once the infection is cleared. 
Matrix metalloproteinases (MMP) appear in the wound fluid in the early inflam-
matory stage but decrease in quantity within 24―48 hours, when particularly the 
decrease of MMP 9 activity, correlates positively with the deposition of collagen 
in the wound area.
Stage of late inflammation. Complement, blood clot, immunoglobulin G (IgG) 
fragments, collagen and elastin breakdown fragments, and cytokines such as leu-
kotriene B4, platelet factor IV, PDGF and TGF-β attract blood monocytes into the 
wound area. The monocytes are transformed to tissue macrophages and act as 
regulatory cells for wound repair in the late stage of the inflammatory phase. These 
cells release cytokines and growth factors which recruit and stimulate fibroblasts, 
keratinocytes and endothelial cells. For wound debridement, the macrophages re-
lease proteolytic enzymes (e.g., collagenase). To stimulate the inflammation, the 
tissue macrophages secrete transforming growth factor-alpha (TGF-α), heparin-
binding epidermal growth factor (HB-EGF), and fibroblast growth factor (FGF). 
Lymphocytes enter the injured tissue in the inflammatory phase (>72 hours after 
the wounding), due to the influences of IgG and complement, and particularly due 
to the influence of interleukin-1 (IL-1) of macrophage and endothelial cell origin. 
The IL-1 further regulates the collagenase activity, and, thereby plays a role in the 
modeling of the extracellular matrix (ECM). 
Stages of proliferation, fibroblast migration and formation of granulation tis-
sue (2―4 day). In this phase, granulation tissue is formed from the fibrin/fibronectin 
matrix.  PDGF and TGF-β attract fibroblasts and myofibroblasts into the wound 
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area at days 2 to 4. These cells migrate, proliferate and produce the new ECM com-
posed of fibronectin, hyaluronic acid (HA), collagen, and finally of proteoglycans. 
The granulation tissue, a pink granular tissue made up of numerous loops of 
capillaries easily bleeds if traumatized. It is composed of macrophages intermixed 
with collagen, glycosaminoglycans (GAGs), fibronectin and tenascin. It appears as 
early as 48 hours after wounding, and the fibroblasts become its predominant cell 
type at 96 hours. 
Stage of epithelialization. Within a few hours from wounding of the skin, a 
single layer of epidermal cells loosen the attachment to the dermis and begin to 
migrate from the wound edges over the provisional matrix and granulation tissue. 
When the moving cells collide, a new basement membrane is generated. The re-
epithelization progresses if the wound is kept moist. The growth factors modulate 
this epithelialization. EGF, bFGF and keratinocyte growth factor stimulate epithelial 
mitogenesis and proliferation.
Stage of remodeling. The remodeling of ECM is characterized with an ongoing 
synthesis and breakdown of native and newly synthesized collagen. The MMPs that 
are produced by fibroblasts, granulocytes and macrophages degradate the collagen. 
As the remodeling is completed, the MMP activity decreases and the inhibitors of 
metalloproteinases appear and increase in activity. TGF-β plays a role in accom-
plishment of the events. 
The final remodeling of a wound takes place when the contractile ECM shrinks 
and the wound margins converge with interactions between fibroblasts and ECM, 
with the influences of TGF-β, PDGF and FGF. During this remodeling, the capil-
laries decrease in number and the blood flow is reduced. An acellular, avascular 
scar is the final result.
It is considered that the collagen fibers in a scar never regain the same strength 
as they have in unwounded skin, and that 80 percent of the strength of the collagen 
in unwounded skin can be achieved at maximum. 
Angiogenesis. Appearance of new blood vessels occurs during all stages of wound 
healing. It is a complex process including interactions between proangiogenetic 
mediators (e.g. vascular endothelial growth factor (VEGF), TGF, PDGF, IL1 and 
IL6) and angiogenetic inhibitors (e.g. inadequate ECK degradation, growth factor 
imbalance, problems in signal transduction). Angiogenesis is characterized by ECM 
degeneration and endothelial cell proliferation and migration. By means of chemo-
tactic and mitogenic factors endothelial cells begin to elongate and form capillary 
sprouts. As the collagen forms a scar, and tends to accumulate in the granulation 
tissue, angiogenesis will diminish. Up- or downregulation of any factor in the nor-
mal process of angiogenesis can result in disruption of the wound healing process. 
Wound contraction, Myofibroblast. Contraction of wound borders and secretion 
of new extracellular matrix are requirements for the final healing. Myofibroblasts 
arise from fibroblasts induced by mechanical stress, TGF-β and cellular fibronectin. 
They synthesize collagens (type I and III), which are main components of the final 
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wound ECM. At the same time high contractile forces are generated by the myofi-
broblasts which are beneficial in the wound healing process. An overexpression of 
this phenomenon is the manifestation of a hypertrophic scar.
1.3.4  FAILURES IN WOUND HEALINg
Several molecular processes may fail, when the wound will not heal properly. The 
failures in one or more molecular or regulatory factors can lead to a chronic wound, 
and may be summarized as follow (Witte et al. 1997, Cross et al. 2003):
Inflammatory response and wound infection. The normal inflammatory re-
sponse can be altered and prolonged in chronic wounds. A microbial infection 
attracts PMNLs that may hamper the progress of the sequential phenomena in 
acute wound healing, and will, thereby, result in a chronic wound. The macrophage 
activation, essential for the release of cytokines and growth factors to recruit fi-
broblasts, keratinocytes and endothelial cells, may be suppressed, resulting in a 
distortion and prolongation of the inflammatory stage (Moore et al. 1997, Boyce 
et al. 2000). In non-healing leg ulcers, the pro-inflammatory cytokines, IL-1, IL-6, 
tumor necrosis factor -α (TNF-α), prostaglandin E2 and thromboxane are present 
in high concentrations indicating an augmented inflammatory phase of wound 
healing (Trengove et al. 2000). 
The continued presence of bacteria in a wound, and the subsequent wound 
infection, may lead to endotoxin production. Although inflammation is a part of 
normal wound healing, the repair process may be delayed if the inflammation is ex-
cessive and destructive. Chronic colonization by bacteria forms biofilms (permanent 
bacterial colonies in extracellular polysaccharide matrix) that are resistant to the 
actions of host defense, and resistant to antimicrobial agents, thereby contributing 
to delayed healing in the wounded area (Davey et al. 2000). 
Protease activity. In chronic wounds the synthesis and degradation of granu-
lation tissue and ECM may be disturbed. The levels of collagenase, gelatinase and 
neutrophil elastase have been shown to be elevated in tissue samples from pres-
sure ulcers and chronic venous leg ulcers (Grinnell et al. 1996, Yager et al. 1996, 
Schultz et al. 1998). 
Cellular activity and cell morphology.  The function and metabolic activity of 
the tissue and inflammatory cells may be impaired. Fibroblasts tend to be larger 
and more polygonal in shape in chronic wounds compared with the normal skin 
fibroblasts (Stanley et al. 1997). Proliferation and mobility of the fibroblasts isolated 
from chronic venous leg ulcers, and from pressure ulcers, are reported to be abnor-
mal in comparison with the fibroblast from normal skin (Van de Berg et al. 1998, 
Agren et al. 1999, Raffetto et al. 2001). A failure in re-epithelialization is perhaps 
the most prominent clinical feature in chronic wounds, this failure being associ-
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ated with deficiency in migration rather than in proliferation of the keratinocytes 
(Adair 1977, Andriessen et al. 1995). 
Extracellular matrix. Failures in composition of the ECM are one class of defi-
ciencies when the wound does not heal. The ECM proteins such as e.g. fibronectin 
are shown to be decreased in quantity in chronic wounds, and the quantity of col-
lagen synthesized by fibroblasts tends to be decreased (Herrick et al. 1992, Herrick 
et al. 1996). Failures in expression of the MMPs may contribute when there are 
defects in collagen deposition (Agren et al. 1998). Failure in the accumulation of 
collagen in the granulation tissue may further be the cause of delayed wound healing 
(Lauer et al. 2000). Fibroblasts in chronic wounds have been demonstrated to have 
a reduced ability to synthetize type I collagen, suggesting failure in the appearance 
of proper ECM during the scar remodeling stage (Cook et al. 2000). 
Free radicals. Appearance of reactive nitrogen (nitric oxide; NO) and oxygen-
derived free radicals originating from the PMNL are implicated in development 
and persistence of chronic wounds. This appearance and action of free radicals can 
be opposed and reversed with internal antioxidants (e.g., synthesis of hyaluronic 
acid by fibroblasts and myofibroblasts), or with external addition of antioxidants 
(Salim 1991, Abd-El-Aleem et al. 2000, Hemmati et al. 2011). In diabetic patients 
with recurrent neuropathic and neuroischaemic leg ulcers, the plasma levels of NO 
have been shown to be significantly increased compared to the levels in patients 
with non-recurrent ulcers (Jude et al. 2001).
Patient specific reasons. Many diseases (e.g. diabetes mellitus, malignancies), 
medicines prescribed (e.g. immunosuppressive medication), living habits (e.g., 
smoking) and mechanical or even psychological factors may impair wound repair, 
resulting in chronic and complicated wounds or ulcers. None of the treatment ef-
forts in topical wound care will result in wound healing, if these patient-related 
background factors and diseases are not taken into account and controlled (Park 
et al. 2010).  
1.3.5  WOUND CARE IN CLINICAL PRACTICE 
The target of chronic wound treatment in clinical practice is its full healing. Treat-
ment is multidisciplinary, and involves, if necessary, surgical wound revision and 
tissue reconstruction in addition to the control and management of mechanical, 
social and medical background factors (Gottrup et al. 2001, Stechmiller et al. 2008, 
Park et al. 2010). In addition to the topical tools, several surgical (reconstructive 
surgery) and device-based options (e.g., negative pressure wound therapy. laser 
therapies, maggots, etc,) for treatment of skin wounds and ulcers are available 
(Vikatmaa et al. 2008, Jokinen et al. 2009, White-Chu et al. 2011). These surgical 
and device-based options are out of the scope of the present study project, and the 
author focuses only on the topical, “conservative” tools in wound care. A recently 
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published systematic review with recommendation is available on the efficacy and 
safety of device-based negative pressure wound treatment in Finland (Juutilainen 
et al. 2007). 
The target of non-surgical and non-device-based topical wound care is the crea-
tion of preconditions for proper healing of the wound including the prevention 
and treatment of wound infections (Clark 1996, Broughton et al. 2006, Velnar et 
al. 2009). Wound care is focused on maintaining and supporting the processes of 
normal wound healing mechanisms, and, in cases with deficiencies in proper heal-
ing, by applying methods and techniques that may reverse the failures.
In clinical practice, chronic skin wounds and ulcers are classified according to 
their clinical appearance as follow: (a) pink wounds indicating that the wound is 
epithelializating, (b) red wounds indicating that the wound is granulating, (c) yel-
low wounds indicating that the wound is covered with fibrin and (d) black wounds 
indicating that the wound is necrotic, and is not healing (Cuzzell 1988).
The topical wound care can be divided into debridement, control of the infec-
tion, and control of the moisture balance.
Debridement of the wound from all necrotic and foreign material is one of the 
most important and first steps in wound care (Steed et al. 1996, Attinger et al. 
2001). Selection of the right methods for the debridement (surgical vs. chemical) 
is dependend on the wound characteristics, the patient´s overall status, and on the 
facilities of the clinic. The combinations of different methods may be useful and 
beneficial (Dissemond et al. 2004). The goal of the debridement, regardless of the 
method, is to achieve a clean wound bed. 
Surgical debridement is the most effective method to remove necrotic tissue and 
impurities. In inborn autolytic debridement, the patient´s own proteolytic enzymes 
and macrophages dissipate necrotic material in the wound. For activation of these 
internal phenomena, the preservation of a moist wound environment and proper 
topical wound care are the requirements. These can be achieved and supported 
with wound care products. Externally applied proteolytic enzymes may be used to 
dissipate and debride necrotic material from the wound base. A combination of 
surgical debridement with external enzymatic debridement has been shown to be 
effective (Ramundo et al. 2008).
Biological debridement may also be carried out with maggots (Lucia sericata). 
The effectiveness of this method in wound healing, as well as its cost-effectiveness, 
has not yet been reliably proven (Hall 2010).
1.3.6  CONTROL OF INFECTION  
The differential diagnosis between wounds with an infection or with simple con-
tamination with microbes is essential but problematic in clinical practice (Rondas 
et al. 2009). Oral antibiotics are recommended if systemic complaints and clinical 
26
INTRODUCTION
signs of a wound infection appear. Contamination or colonization of wounds by 
bacteria is not an indication for treatment with antibiotics. Antibiotics do not ac-
celerate wound healing in these cases (Alinovi et al. 1986, Wikström et al. 1999). 
Topical antibiotics are not useful and are not accepted in the treatment of chronic 
wound and ulcers, mainly due to problems with bacterial resistance (O´Meara et 
al. 2010). Sugar, honey and silver are antimicrobial and considered as acceptable 
topical agents for infection control even in chronic wounds (Meaume et al. 2005, 
Mphande et al. 2007).
1.3.7  CONTROL OF MOISTURE 
The wound should not dry up but should not be too wet either. Careful control 
of the moisture balance helps the proper evolution of all molecular and cellular 
stages of wound repair. Necrotic and infected wounds with abundant exudation are 
recommended to be covered with hydrofiber, alginates or polyurethane dressings, 
which have enough absorption capacity. In dry wounds or in wounds with slight 
exudation, moisture maintaining dressings, such as hydrogels and hydrocolloids, 
are recommended (Iivanainen et al. 2011). 
1.3.8   DRESSINgS IN PRACTICAL WOUND CARE   
Topical dressings in wound care are divided in passive, active and interactive dress-
ings. Passive dressings protect the wound, active dressings affect the wound healing 
process and interactive dressings react with exudation and can thereby have an effect 
on wound moisture. Wound care products in general are classified to the category 
“medical device” with one exception. Collagenase (Clostridiopeptidase A), used in 
enzymatic cleaning of the wound is categorized in Finland as a medicinal product. 
In available literature, there is no ”gold standard” or strong consensus recom-
mendations for the selection of topical treatment tools, dressings, or equipments 
for wound care (Chaby et al. 2007, Peltonen 2007, Canadian Agency for Drug and 
Technologies in Health 2011). In practice, the treatment methods chosen for wound 
care are based on subjective observations, on personal experience in the wound 
care, and on the availability and price of the available tools in the treatment units. 
Selection of the consumables is not easy. On the market in Finland, there are over 
300 different local wound care products with varying properties and with a large 
variance in consumer price (Iivanainen et al. 2011). A summary of different types 
of wound dressings and other consumables available in Finland at present is pre-
sented in Appendix II (Iivanainen et al. 2011).
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2. OBJECTIVES OF THE PRESENT STUDY PROJECT 
Answers were sought to the following specific questions:
1. Is the natural coniferous resin and resin salve antimicrobial?
2. Is the antimicrobial activity specific and what are the mechanisms?
3. Is the resin salve treatment safe?
4. Is the coniferous resin salve effective in the treatment of pressure ulcers 
and chronic surgical wounds in clinical trials?
5. What are the direct costs of the pharmaceutical materials in treatment of 
chronic surgical wounds with the coniferous resin salve? 
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3. MATERIALS AND METHODS
3.1 SPRUCE RESIN AND RESIN SALVE (paper I–VI)
The resin for all studies in the present project was collected in Kolari, Finnish Lap-
land, from the trunks of full-grown Norway spruce (Picea abies) with knives, with 
the permission of the landowners. Bark and other impurities were removed from 
the resin by mechanical cleaning and the resulting solid resin (crude raw material) 
was stored at room temperature until further processed. 
The resin salve used in the randomized controlled trial (paper V) was a mixture 
of Norway spruce resin and salt-free butter (Valio Ltd., Helsinki, Finland). The salve 
was prepared according to the common practice in traditional medicine (Timo Kyrö, 
personal information, 2006). The raw coniferous resin was mixed and boiled with 
salt-free ordinary butter (Valio Ltd., Helsinki, Finland) by stirring in a weight pro-
portion of 1:3 (w/w), filtered and allowed to cool to room temperature, and finally 
packed into tubes in the University Pharmacy, Helsinki, Finland. 
The resin salve applied in the observational clinical trial, mycological trials and 
morphological and electrophysiological investigations was a mixture of purified resin 
with a standardized salve base produced by the GMP standards (Abilar 10% resin 
salve, Repolar Ltd., Espoo, Finland) (papers II―IV, VI). The resin (raw material) 
was, after mechanical purification, dissolved for 3―4 weeks in ethanol at room tem-
perature, and filtered resulting in an ethanol solution with a resin content around 
65% (w/w) (Patent FI 122095 B). This alcohol-coniferous resin solution was used 
as the active ingredient in the industrially manufactured, “modern” resin salve. This 
salve and its dilutions (dilutions with salve base) were used in the challenge tests 
and in the mycological investigations (papers II and III).  
3.2 MICROBIOLOgy (paper I–III)
To study the antimicrobial properties of resin and resin salve various techniques 
were used. This was done because of the poor water solubility of the compounds 
in resin and resin salve. Agar diffusion test is largely based on the solubility of 
the test material in solid agar. The zone of inhibition may be small due to poor 
solubility even though the test material is highly antimicrobial. The liquid media 
test is a sensitive method and not dependent on diffusion in solid agar. Instead of 
29
assessing zonal inhibition, visual monitoring of turbidity is used to evaluate the 
antimicrobial property. 
In the agar diffusion and agar liquid tests, the test material is placed on bacteria 
grown in culture. In the challenge test, by contrast, the bacteria are placed on the 
test material after which the antimicrobial effect of the test material is assessed by 
the number of micro-organisms recultured after a specific incubation period. An-
timicrobial action in this test is not dependent of water solubility.
Minimum inhibitory concentration (MIC) is the lowest concentration of tested 
material showing antimicrobial activity. A low MIC is an indication of a potent 
antimicrobial effect. 
The microbial strains used in the microbiological studies are presented in appendix 
III.
3.2.1  AgAR DIFFUSION TESTS (paper I)
In the Agar diffusion tests, Mueller-Hinton media were used. Wells with a diameter 
of 8 mm were punched into the agar medium and filled with the resin salve. The 
plates were incubated for 18 h after which zones of inhibition were measured and 
noted. Wells filled with sterile saline without resin were used as controls.
3.2.2  MIC ANALySES (paper I)
The MIC values of the coniferous resin and resin salve were analyzed by mixing 
the purified resin in different concentrations with the agar. Lowest antimicrobial 
concentration was considered as the MIC value. The pulverized resin was added 
into the Mueller-Hinton liquid agar to produce the following final concentrations 
of resin in the medium: 1.0, 0.8, 0.6, 0.4 and 0.2% (w/v). Detailed information is 
given in paper I. The media/resin solutions were autoclaved and poured onto the 
Petri dishes. Bacteria (S. aureus, S. epidermidis, E. faecalis, St. pyogenes and St. 
agalactiae) tested in the MIC experiments were delivered as 1 ml aliquots onto 
the surface of three parallel Mueller-Hinton/resin plates. Inoculated plates were 
incubated and bacterial growth was inspected after 16–20 h. 
3.2.3  LIqUID MEDIA ExPERIMENTS (paper I)
The liquid growth medium used in the microbiological tests was the Fastidious 
Anaerobe Broth (FAB) (Lab M, Bury, England). Due to bacterial growth, the broth 
becomes turbid or - depending on the extent of the bacteria growth - visible colonies 
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are formed. The FAB medium was used because of its semisolid property which 
made it possible to directly observe or even count the number of colonies of bacteria 
growing in the medium. The experiments with the FAB medium were performed 
in two different ways.
First, the bacteria tested were inoculated into the FAB media with or without 
resin salve. The colonization of the bacteria was visually examined and recorded 
as absent, mild, moderate, or heavy. 
Second, the FAB media with or without a pretreatment with the resin salve were 
prepared. In preparing the resin-pretreated FAB medium, a layer of resin salve was 
spread on the bottom of a Petri dish, after which the FAB solution was layered on 
this resin bed. After incubation of 3 hours, the FAB medium was collected. This 
FAB medium pretreated with the resin salve did not differ macroscopically from 
the FAB medium that was not pretreated with the resin salve. The culture experi-
ments were carried out in the FAB media with and without the pretreatment with 
the resin salve.
The growth of bacteria in the test tubes was visually monitored. The antibacte-
rial activity was detected as a decreased turbidity in cultures containing resin as 
compared to those without resin. After the liquid culture tests, subcultures on agar 
plates were performed in order to determine whether the resin killed the bacteria 
or only inhibited their growth (bactericidal vs. bacteriostatic action).
3.2.4  EUROPEAN PHARMACOPOEIA (Ph. Eur.) CHALLENgE TESTS (paper II)
In challenge tests, the antimicrobial action of the resin was tested against bacteria 
and fungi. The tests were performed by adding bacteria (105-107 cfu/ml) or fungi/
yeasts (104 or more cfu/ml) to 10 g of test medium (resin, resin salve or control) 
as challenged micro-organisms. If the microbes remain viable and re-cultivable 
in the challenge test, the test substance is considered to exert no bacteriocidic or 
fungicidic influences.
The re-growth of microbes from the challenged test medium was assayed by 
sampling at different time intervals (up to 7 days). Samples were re-cultured in spe-
cific media and a reduction in growth intensity of the challenged micro-organism 
was assessed as colony forming units (cfu). According to the European Pharma-
copoeia (European Pharmacopoeia 5.0) challenge test criteria, a reduction of the 
bacterial count by at least by 102 cfu within 48 h and by at least by 103 within 7 
days is considered to indicate a significant bactericidal activity of the substance 
under test. Correspondingly, a reduction in yeasts of at least 102 cfu within 14 days 
is considered fungicidal.
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3.2.5  AgAR PLATE DIFFUSION TESTS IN MyCOLOgy (paper III)
Coniferous resin or resin salve in different dilutions with the salve base was applied 
and poured into 9 mm diameter holes in specific agar gel. Samples of sterile saline 
without resin were used as controls. The plates were incubated and the size of the 
inhibition zone was measured for yeasts at 24-48 hours and for dermatophytes at 
7 days. 
3.3 MORPHOLOgICAL AND ELECTROPHySIOLOgICAL STUDIES  
 (paper III–IV)
3.3.1  ELECTRON MICROSCOPy, BACTERIOLOgy (paper IV)
Diluted cultures of S. aureus were transferred onto a layer of purified resin or 10% 
(w/w) resin salve on the Petri dishes and incubated for 18 hours. Thereafter, the 
specimens for the electron microscopy were prepared from the samples of cultivated 
bacteria from the Petri dish. Pure S. aureus bacteria cultures without exposure to 
the resin or resin salve were used as controls. 
Specimens for the electron microscopy were prepared at the Institute of Biotech-
nology, Electron Microscopy Unit, University of Helsinki, Helsinki, Finland, (Kari 
Lounatmaa Sc.D. (Biol.)). Transmission electron microscopy (TEM) examinations 
were done in the same institute. The scanning electron microscopy (SEM) examina-
tions were done in the Department of Electronics, School of Electrical Engineering, 
Aalto University, Espoo, Finland, (Kari Lounatmaa Sc.D. (Biol.)).
Morphometric analyses of 55 randomly assigned TEM micrographs (1–5 S. 
aureus bacteria in each) were carried out by counting the cell diameter, cell wall 
thickness, number of mitoses, and the cross-sectional area of the bacteria. 
The cell diameter and the cell wall thicknesses at opposite sites were measured 
in all cells that were clearly and fully visible in the micrograph. The number of mi-
toses, defined as two ‘‘sister’’ cells with a complete or incomplete common cell wall 
and cell membrane, were assessed individually for each image, and the cumulative 
numbers of such cells were calculated.
3.3.2   ELECTRON MICROSCOPy, MyCOLOgy (paper III)
Samples for TEM and SEM were taken from the Trichophyton mentagrophytes 
agar diffusion culture plates (see 3.2.5 Agar plate diffusion test in mycology) from 
2 sites:  first, from a site where no inhibition to growth of the fungi was observed 
and, second, from a transitional zone between the areas of the inhibition zone 
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and zone of normal growth. The electron microscopy specimens were prepared as 
described above and in detail in paper IV.
3.3.3  ELECTROPHySIOLOgICAL STUDIES (paper IV)
The effect of the spruce resin and abietic acid on the bacterial membrane potential 
was measured by flow cytometry and the BacLight Bacterial Membrane Potential 
Kit. The resin and abietic acid were transferred to glass beakers, and the diluted S. 
aureus suspension (4ml) was poured to the beaker in duplicates. S. aureus without 
the exposure to the resin or abietic acid was used as control. After incubation, 1ml 
of bacterial suspension from each beaker was transferred into plastic cuvettes with 
specific commercial reagents to measure the fluorescence shift from the red emis-
sion toward the green emission. This shift takes place if the membrane potential 
of the bacterial cells diminishes.  
Fluorescence in flow cytometry was measured at 615nm (red) and 518nm (green). 
The intensities of the red and green fluorescence were recorded for each sample. 
The mean fluorescence intensity (MFI) ratiometric parameter (MFIred : MFIgreen) 
describes the strength of the membrane potential.
The electrophysiological studies were done in METLA (Finnish Forest Re-
search Institute, Rovaniemi) (Rainer Peltola, Ph.D. and Minna Männistö, Ph.D.).
3.3.4  ANALySES ON FATTy ACIDS (paper IV) 
Resin diluted in DMSO/Tryptic Soy Broth (TSB-medium) with a resin concentration 
of 0.1% (w/v) was prepared. DMSO without resin was used as a control medium. 
1ml of S. aureus was transferred onto both media, and incubated. After measuring 
the bacterial density, the solution was centrifuged and washed to get pellets. Bacte-
rial fatty acids were extracted and the amount of branched chain and straight chain 
fatty acids was measured with gas chromatography in METLA (Finnish Forest Re-
search Institute, Rovaniemi) (Rainer Peltola, Ph.D. and Minna Männistö, Ph.D.).
3.4 OTHER ANALySES
3.4.1.  gLC/MS ANALySES 
The gas-liquid-chromatographic (GLC) analyses with mass spectrometry (MS) of 
the coniferous resin and resin salve were performed in METLA (Finnish Forest Re-
search Institute, Helsinki) (Tapio Laakso, M.Sc. and Pekka Saranpää, Ph.D.). Water 
or acetone extracts of resin or resin salve were obtained by sonication for 1 hour in 
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anultrasonic bath then evaporated dry under nitrogen. Before the GLC/MS analysis, 
dried samples were silylated with 0.5ml 20% TMSI (trimethylsilylimidazole)-pyri-
dine mixture. The GLC/MS analyses were performed with the HP 6890 GLC-system 
equipped with mass selective detector 5973 and an HP-5 capillary column (30m x 
0.25 mm i.d., 0.25 micrometer film thickness). Helium was used as carrier gas, flow 
1.5 ml/min. The chromatographic conditions were as follows: initial temperature 
180oC, temperature rate 5oC/min, final temperature 300oC for 5 min; injection 
temperature 280oC and split ratio 1:20. The MS- interface temperature was 300oC 
and the ion source temperature 230oC. Mass spectra were obtained by electron 
impact (EI mode) at ionization energy 70 eV (Sipponen et al. 2007).
 3.4.2  AMES TESTS
The Ames genotoxicity tests of resin and resin salve were performed with Salmo-
nella typhimurium  (TA98 and TA100 strains) with or without S9 rat liver metabolic 
activation factor by Jorma Mäki-Paakkanen, Ph.D., at the THL (National Institute 
for Health and Welfare, Kuopio, Finland) with the standard and usual techniques 
(Mortelmans et al. 2000). 
3.4.3  SkIN IRRITATION TEST
Skin irritation tests and in vitro cytotoxicity tests on the coniferous 10% resin salve 
were done by LAB Research (Scantox), Copenhagen, Denmark (unpublished data). 
The skin irritant effect was investigated according to the ISO (The International 
Organization for Standardization) 10993-10:2010 standard.  Three female rabbits 
were exposed to 0.5 g of the resin salve at each of two sites on the back.  After a 
4-hour exposure period, the test item was removed and the skin was examined 
1, 24, 48, 72 hours after termination of the exposure, and on day 8. The skin 
reactions to salve were read according to the appearance of erythema and edema. 
Finally the primary irritation index was calculated (scale: 0-8).
3.4.4  CyTOTOxICITy TEST
The in vitro cytotoxicity test for 10% coniferous resin salve was done according to 
the ISO 10993-5:2009 and USP<87> (U.S.Pharmacopeia biological reactivity tests, 
in vitro) guidelines. Salve was extracted to the HAM F12 medium (containing 10% 
foetal bovine serum and 50 microg/ml gentamycin). The extract was obtained by 
mixing of 4.26 g salve with 21.3 ml of cell culture medium for 24 hours at 30oC. 
L929 mouse fibroblasts (ECACC No. 85011425) were added to this medium, or to 
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a diluted medium (1+3), and were cultured at ca. 37oC in a humidified atmosphere 
of 5% carbon dioxide in air for 48 hours. Thereafter, the number and percentage 
of viable cells were calculated. The scale of cytotoxic reactivity in the test is 1―4. 
Grade 4 indicates severe cytotoxicity (nearly all cells are destroyed). Grades 1, 2 and 
3 indicate slight (≤20% of cells are destroyed), mild (≤50% of cells are destroyed) 
or moderate (≤70% are destroyed) cytotoxicity, respectively.
3.5 CLINICAL TRIALS (paper V–VI) 
3.5.1  A RANDOMIzED, CONTROLLED TRIAL (RCT) IN PATIENTS WITH  
 PRESSURE ULCERS (paper V)      
The study was a prospective, randomized, open-label but controlled multicentre 
investigation designed to compare the effectiveness of the resin salve treatment with 
a generally accepted control treatment (carboxymethylcellulose hydrofiber polymer 
dressing with or without silver (Aquacel® or Aquacel Ag®)) in patients with severe 
pressure ulcers (grade II–IV). 
In each study center, the patients were randomized into the resin salve and 
control group by using mixed block randomization (closed envelopes in blocks of 
four cases).
The primary outcome measure was complete healing of the ulcer within 6 
months. The healing rate was recorded in both study arms (resin salve group vs. 
control group) as a function of time (percentage of patients healed in time units 
and percentage of ulcers healed in time units). The secondary outcome measures 
were the improvement of the ulcer grade (ulcer size), and the prevalence rate of 
successful eradication of the pathogenic bacteria cultured from the ulcers at study 
entry. Safety was followed with adverse event reports. 
The study population was recruited in 11 primary care hospitals (health centers). 
After the randomization, there were 21 and 16 patients in the resin salve group and 
in the control group, respectively. Altogether 22 patients (9 males and 13 females; 
mean age 80 ± 10 years and 74 ± 8 years) with 45 pressure ulcers went through the 
6 month study course. There were 8 and 7 patients, respectively in the resin group 
and control group who dropped out for various reasons. All these dropouts were 
included in the intention-to-treat (ITT) analysis of the study results. The treatment 
was considered to be failed in the ITT analyses in all of these dropouts.
The patients recruited and selected into the present study population were con-
sidered ineligible for surgical treatment options (plastic surgery), or had undergone 
one or more surgical treatment efforts for ulcer without success in the past. The 
inclusion criterion was one or several severe pressure ulcers (grade II–IV) with 
or without infection. The exclusion criteria were a life expectancy of less than 6 
months, or the patient´s unwillingness to participate.
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All ulcers were photographed, and planimetric analyses of the ulcer size were 
recorded at study entry and monthly thereafter. If the ulcer was not healed in 6 
months, the treatment was considered unsuccessful, and follow-up was discon-
tinued.
3.5.2  AN OBSERVATIONAL CLINICAL COHORT STUDy IN PATIENTS WITH  
 CHRONIC SURgICAL WOUND (paper VI)  
The trial was a prospective observational clinical investigation of a cohort includ-
ing 23 patients (mean age 49 ±17 years;  8 males and 15 females) whose surgical 
wound (length of the open wound 29 ±19 mm; range 5-60 mm, at study entry) did 
not heal by primary intent after elective surgery, and the wound was considered, 
therefore, chronic and complicated. The primary outcome measure was the time in 
days to complete wound healing. The secondary outcome measures were to assess 
the contributors (clinical parameters) that may delay the wound healing, to estimate 
the direct costs of the pharmaceutical materials in resin salve therapy and the rate of 
allergic contact dermatitis, or the appearance of other possible side effects. The study 
population was collected from patients referred to routine postoperative controls in 
the outpatient departments of two hospitals, the Rheumatism Foundation Hospital 
(Heinola, Finland) and the Jorvi Hospital (Helsinki University Central Hospital, 
HUS, Espoo, Finland). In all cases without exception, the resin salve treatment was 
carried out by the patients themselves (self treatment) as home care.
3.5.3  CALCULATION OF THE DIRECT COSTS OF THE PHARMACEUTICAL  
 MATERIALS (paper VI)
Calculations of direct costs of the pharmaceutical materials from the study entry 
until wound healing were assessed in all individuals separately and extrapolated, 
thereafter, to the whole study population. The consumer prices of the Abilar® 10 
% resin salve and the Tyke HealthCare cotton gauze in the University Pharmacy in 
Finland in April 2011 were used as prices of the salve and accessories (dressings). 
The following variables were taken into account in assessments of the consump-
tion and need of the salve and the accessories in every patient: 1) wound size, 2) 
daily consumption of salve extrapolated in relation to the wound size, 3) wound 
healing time, 4) number of 20 g salve tubes purchased during the treatment period 
per patient, 5) price of the 20 g salve tube, and 6) price and package sizes of the 
accessory products (dressings).
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3.5.4 STATISTICAL ANALySES (paper V-VI)
In the randomized, controlled trial (paper V), data analyses and reporting were 
based on the CONSORT statement and in the observational cohort study (paper 
VI) on the STROBE guidelines (Moher et al. 2001, von Elm et al. 2008). Mean and 
standard deviation were computed for quantitative data (continuous variables), 
while frequencies and percentages were computed for qualitative data (dichoto-
mous variables). Continuous variables and proportions were compared using the 
Mann-Whitney non-parametric U-test or Student`s t-test. 
In the randomized study differences between the groups were compared with 
the χ2 test or Fischer`s exact test. Healing of ulcers over time was defined with 
Kaplan-Meier analyses. The log-rank test was used to compare healing times in 
the two study groups. A p-value of < 0.05 was considered statistically significant.
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4. RESULTS
4.1 MICROBIOLOgy (paper I-III) 
4.1.1  CULTURE MEDIA TESTS ON BACTERIA (paper I)
Coniferous resin and the resin salve exhibited a clear antimicrobial effect against 
all Gram-positive bacteria tested including the methicillin-resistant Staphylococcus 
aureus (MRSA) and the vancomycin-resistant enterococcus (VRE), but only against 
Proteus vulgaris of the Gram-negative bacteria tested in the agar diffusion tests. 
In the agar diffusion test, a drop of resin salve laid on the agar showed a narrow 
but clearly visible inhibition zone against the susceptible bacteria (e.g., S. aureus). 
The addition of sterile saline on the salve drop resulted in inhibition of the growth 
of bacteria in the whole area where the saline was spread out on the plate. In the 
FAB liquid growth medium, a drop of resin salve in the culture medium showed 
clear antibacterial activity and inhibited the growth of the bacteria in the medium 
(Fig. 2). Equally, the resin-pretreated FAB medium, up to a dilution of 1:2 with 
fresh FAB, was antibacterial in agar tests against S. aureus. Inhibition disappeared 
at dilutions of 1+5, or more.
The minimal inhibitory concentration values (MIC) of the spruce resin varied 
among bacterial strains tested. The MIC values of the purified spruce resin were 
0.2% (w/v) against the bacteria of genus Streptococcus, followed by Staphylococ-
cus 0.4% (w/v) and Enterococcus 0.4―0.6% (w/v). The MIC values against the 
Gram-negative bacteria and P.vulgaris bacterium were over 1% (w/v).
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4.1.2  EUROPEAN PHARMACOPOEIA (Ph. Eur.) CHALLENgE TESTS (paper II)
The resin dissolved in ethanol (A12t) immediately killed all bacteria tested in the 
challenge tests. All microbes inoculated were, however, re-cultivable from the resin 
or resin salve medium within 1 hour when the resin was alcohol-free. However, the 
number of re-cultivable bacteria diminished significantly in the inoculums when 
exposed to the purified resin or resin salve in the challenge test for longer than 1 
hour. The challenge of microbes with 10% resin salve medium reduced the number 
(reduction >104 in colony forming units) of Staphylococci within 24 h and, corre-
spondingly, also significantly reduced the colonization of all other microbes tested 
within 4 days. The pure salvebase medium (control) or the 0.5% resin salve did not 
show any reduction in the re-growth of the microbes within 7 days. 
The 2% resin salve medium showed a significant antimicrobial effect against 
staphylococci and C. albicans within 7 days, but it did not influence B. subtilis and 
showed only mild activity against E. coli and P. aeruginosa.
The challenge tests gave somewhat controversial results in microbial sensitiv-
ity to resin or resin salve compared to the agar diffusion testresults (Table 1). The 
Figure 2 the culture of the mrsA bacterium in the FAB medium in six test tubes without (a) or with an 
addition of a drop (0.05 ml) of 10% resin salve (b). the inoculated suspension of mrsA was adjusted to 
match the 0.5 mcFarland turbidity standards and was serially diluted (10-fold) from 10-1 to 10-6. An inoculum 
of 100 microL of undiluted suspension and appropriate dilutions were added to each tube containing 900 
microL of medium. the tubes were incubated at 35 ±2 oc for 18 hours.
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growth of some Gram-negative rods (e.g., E. coli and P. aeruginosa) were not in-
hibited by the resin in the agar diffusion test but were clearly sensitive to resin in 
the challenge test.
4.1.3  AgAR PLATE DIFFUSION TESTS IN MyCOLOgy (paper III)
In the agar diffusion tests, an antifungal effect of the resin salves was observed against 
all dermatophytes tested, particularly against the fungi of the Trichophyton species. 
The strength of the antifungal activity (size of the inhibition zone) was dependent 
on the concentration of resin in the salve.  Resin in a concentration of 10% showed 
a clear but slight antifungal action, whereas the salve with a resin concentration of 
20% or more caused a strong and significant fungistatic effect (Fig. 3). 
In the agar plate diffusion test, Candida yeasts were insensitive to the resin, 
with the exceptions of C. glabrata and C. krusei where a narrow inhibition zone, 
however, appeared. 
Figure 3 examples of the agar plate diffusion tests of the resin salve against Trichophyton rubrum (a) and 
Trichophyton mentagrophytes (b). the antimycotic activity tends to increase (size of the inhibition zone 
increases) with an increase in the concentration of the resin in the salve.
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Microbe species studied        Growth of                                                                European Pharmacopoeia challenge test.
       bacteria in                                                          Growth of micro-organisms after the challenge.
     FAB medium                                                                Re-growth in cfu/ml units
FAB FAB-resin Salve base Resin 10% Salve base Resin 10%
only in salve base only in salve base 
24 h 24 h 4 days 4 days
Gram-positive cocci
Staphylococcus aureus +++ - >log 3 log 1/- >log 3 -
Staphylococcus epidermidis +++ -
Enterococcus faecalis +++ -
Streptoococcus pyogenes +++ -
Streptococcus agalactiae +++ -
Gram-positive rods
Arganobacterium haemolyticum + -
Bacillus subtilis >log 3 log 3 >log 3 log 1
Gram-negative rods
Escherichia coli +++ +++ >log 3 log 3 >log 3 log 1
Klebsiella pneumoniae +++ +++
Proteus vulgaris +++ -
Proteus mirabilis +++ +++
Pseudomonas aeroginosa +++ +++ >log 3 log 3 >log 3 log 1
Yeasts
Candida albicans >log 3 log 1 >log 3 -
Abbreviations: +++, ++, +, - = strong, moderate, mild or no growth growth of bacteria in  the culture medium.
Log 3, log 2 and log 1 indicate the growth of microbes in intensities of 103, 102 or 1-10 cfu/ml. The abbreviation (-) indicates 
that no no-micro-organisms could be re-cultivated from the sample.
Table 1 A summary table on the results of the antimicrobial effects of the norway spruce callus resin and resin salve against selected 
microbes in the FAB culture medium and in the european Pharmacopoeia challenge test. note that the tests provide somewhat 
controversial results regarding the Gram-negative bacteria. these micro-organisms tend to be insensitive to resin in tests with the 
FAB medium (and in agar plate test) but sensitive in the challenge test.
4.2 MORPHOLOgICAL AND ELECTROPHySIOLOgICAL STUDIES  
 (paper III–IV) 
4.2.1  ELECTRON MICROSCOPy, BACTERIOLOgy (paper IV)
The exposure of the S. aureus cultures to the coniferous resin or resin salve re-
sulted in alterations in structure of the microbial cell walls (Fig. 4). In the TEM 
micrographs, no changes in cell volumes were seen but the cell walls in bacteria 
exposed to resin were significantly thicker than those in the normal cells, or in the 
cells exposed to the salve base alone. The adhesion properties of the bacteria were 
also affected. In the SEM and TEM micrographs, the bacteria exposed to the resin 
tended to adhere and formed multicellular aggregations. In the TEM images the 
number of cells with septa-like structures was significantly more numerous in the 
exposed cultures than in the control cultures. 
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4.2.2  ELECTRON MICROSCOPy, MyCOLOgy (paper III)
The exposure of the Trichophyton mentagrophytes cultures to the resin salve caused 
obvious destructions in the cell walls of the fungal hyphae. In the samples taken from 
the outside area of the inhibition zone in agar cultures plates, the fungal hyphae 
looked normal with plentiful spores, whereas in the samples from the inside area 
of the inhibition zone, the fungal cells were visualized with distorted remnants of 
short hyphae. In the samples from the margin area, the cell hyphae looked folded 
and irregular, and the cell walls were granular and flaky. Some hyphae were short 
and looked amputated. Resin seemed to destroy the fungal hyphae segment by 
segment (Fig. 4).  
Figure 4 A panel of photomicrographs of S. aureus bacteria (A-c) and T. mentagrophytes fungi (d,e) 
exposed to the norway spruce callus resin salve. the exposure resulted in thickenings of the microbial 
cell walls, septa-like cell wall structures (arrows; A), disruptions of the cell wall (B) and cell aggregations 
(c). the fungal hyphae are damaged (d) and destroyed segmentally (arrows; e).
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4.2.3  ELECTROPHySIOLOgICAL STUDIES (paper IV)
CCCP (carbonyl cyanide m-chlorophenylhydrazone) is an H+ ionophore that dis-
rupts the transmembrane proton gradient in prokaryotic cells. The DiOC2 (3,3′-di-
ethyloxacarbocyanine iodide) -stained S. aureus cells that were exposed to CCCP, 
spruce resin, or abietic acid, emitted more green than red fluorescence (radiometric 
parameter MFIred:MFIgreen decreased) compared to intact S. aureus cells. The obser-
vations imply that the proton gradient across the cell membrane in these bacteria 
had been disrupted when exposed to the resin or abietic acid.  
4.2.4  ANALySES ON FATTy ACIDS (paper IV)
When the S. aureus cells were cultured in the presence of resin the share of the 
branched-chain fatty acids increased and the proportional share of straight fatty 
acids, correspondingly, decreased. This implies that resin exposure induces struc-
tural changes in the microbial cell walls.
4.3  OTHER ANALySIS
4.3.1 CHEMICAL COMPOSITION OF THE CONIFEROUS “CALLUS” RESIN  
 AND RESIN SALVE (UNPUBLISHED DATA) 
In the gas-liquid-chromatography with mass spectra (GLC/MS), the acetone extracts 
of both pure coniferous callus resin of the Norway spruce, and the salve manu-
factured from this resin, gave very similar and stable chromatograms in repeated 
analyses (Fig. 5). The samples tested showed constantly the presence of coumaric 
acid (hydroxycinnamic acid), a group of resins acids and a group of lignans, similarly 
in both resin and resin salve extracts. The mean concentrations of coumaric acid, 
different resin acids and lignans in acetone extracts from 8 different salve samples 
are presented in Table 2. Among the resin acids, hydroxyabietic acid and abietic acid 
were the most abundant compounds. Pinoresinol was the most abundant lignan. 
The GLC chromatograms or the concentrations of coumaric acid, resin acids or 
lignans in the resin or resin salve remained stable in samples stored over 3 years 
at room temperature. Neither were there changes in the GLC/MS of the resin or 
salve samples kept in a heat chamber (+40oC) for 6 months.
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Figure 5 example of the gas-liquid-chromatography (GLc) of purified coniferous callus resin from the 
norway spruce (Picea abies) and from the salve manufactured from this resin. the GLc/ms analyses 
were done in metLA laboratories (Helsinki, Finland) from the acetone extracts of the purified coniferous 
resin or resin salve.
Table 2 concentrations of various resin acids, lignans and coumaric acid in 10% resin salve. concentrations 
were calculated from the GLc/ms data of the acetone extracts of the resin salve (metla, Helsinki, Finland). 
the analyses are the means of eight salve samples. each analysis was done in duplicate.
Compound Concentration
mg/g
Resin acids
dehydroabietic acid 8.8 ±1.0
abietic acid 6.0 ±1.3
isopimaric acid 3.1 ±0.3
pallusteric acid 2.8 ±0.4
neoabietic acid 2.0 ±0.4
pimaric acid 0.9 ±1.4
levopimaric acid 0.8 ±0.2
Lignans
pinoresinol 7.6 ±1.0
isolaricinol 1.7 ±0.9
laricinol 1.6 ±0.3
secoisolaricinol 0.8 ±0.2
Total
resin acids, total 24.0 ±3.2
lignans, total 10.0 ±1.1
resin acids + lignans, total 32.6 ±5.5
coumaric acid (hydroxycinnamic acid) 4.6 ±0.8
44
RESULTS
4.3.2  ALLERgIC REACTIONS, TOxICITy AND COMPLIANCE (paper V–VI)
In the trial of patients with pressure ulcers (paper V), one patient showed symp-
toms indicating allergic contact dermatitis, and was, therefore, dropped out from 
the study. In the cohort trial in patients with chronic complicated surgical wounds 
(paper VI) there were no observations of any adverse events or allergic reactions. 
In both studies (papers V and VI), altogether 45 patients underwent the scheduled 
treatment up to the end of the study and received resin salve daily for weeks or 
several months. Among these patients, the prevalence rate of allergic contact der-
matitis was 2% (95%CI:0–5%; i.e., one patient out of 45).
The possible mutagenicity of the coniferous resin and resin salve was tested 
with the Ames tests (unpublished data). The test results are presented in Fig.6. In 
repeated tests with two Salmonella typhimurium strains, and with or without the 
metabolic activator, the resin or resin salve did not show any mutagenic properties, 
not even in maximal resin concentrations.
The skin irritation tests and in vitro cytotoxicity tests were performed with the 
coniferous 10% resin salve by an authorized laboratory (unpublished data). In the 
skin irritation test performed according to the ISO 10993-10:2010 standard, the 
10% resin salve caused, in skin of three rabbits, slight (negligible) erythema 24 
and 48 hours after the termination of exposure. The “irritation Index” was 0.1 
(scale 0-8.0), which corresponds to the response category: “negligible” in the 
ISO 10993-10:2010 standard.
In the in vitro cytotoxicity test, the extracts of 10% coniferous resin salve in 
HAM F12 culture medium were cytotoxic against mouse fibroblasts in a 24 hour 
assay (unpublished data). Based on the EN ISO 10993-5:2009 and USP<87> crite-
ria, the cytotoxicity was severe (cytotoxicity grade 4). The diluted extract (dilution 
1+3) of the resin salve showed slight to mild cytotoxicity (cytotoxicity grade 1―2; 
scale of the index: 0―4).
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Figure 6 results of the Ames test with the norway spruce callus resin (a, b, e, f) and with the resin salve 
manufactured from the callus resin (c, d). the tests were performed with Salmonella typhimurium  strain 
tA98 (a, b, d, e) or strain tA100 (c, f). the test was carried out with or without metabolic activation (rat 
liver s9-fraction). the samples of resin or salve were serially diluted in dimethyl sulfoxide (dmso). note 
that all sample results on mutagenicity were at the same level or less than in the results with the dmso 
diluent or water control. All positive controls (4-nPd, B[a]P and nan3) showed a clear mutagenicity.
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4.4   CLINICAL TRIALS (paper V-VI)
4.4.1  A RANDOMIzED, CONTROLLED TRIAL (RCT) IN PATIENTS WITH  
 PRESSURE ULCERS (paper V)
After recruitment of 37 patients, 13 eligible patients in the resin group and 9 patients 
in the control group underwent the 6 month treatment trial (Fig. 7). The correspond-
ing numbers of ulcers were 18 and 11, respectively. Between the treatment groups, 
there were no significant differences in terms of the patient demography, clinical 
appearances or ulcer characteristics.  
Healing rate: In the per protocol analysis, all ulcers healed in 12 of 13 compli-
ant patients in the resin group and in four of nine compliant patients in the control 
group (92% (95%CI: 78―100%) vs. 44% (95%CI: 12―77%); P = 0.003; power 73%) 
during the 6-month treatment period (Fig. 7). The ulcer healing rate (as a func-
tion of time) was significantly better in the resin group than in the control group 
(log-rank test, P = 0.013; Fig. 8). Complete healing of ulcers occurred significantly 
more often in the resin group (94% (95%CI: 84―100%) of the ulcers healed within 
6 months) than in the control group (36% (95%CI: 8―65%); P = 0.003).
In the intention-to-treat (ITT) analysis, and by assuming that all ulcers in pa-
tients dropped out in both study arms did not heal, the healing rate for ulcers were 
63% (95%CI: 45-81%) and 22% (95%CI: 0-41%).
Figure 7 Flow chart of the study design in the randomized controlled trial (rct) and of the prevalence 
rate of patients and ulcers healed in 6 months in the resin and control groups (hydrofiber dressing with 
or without silver (Ag+)).
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Figure 8 Graph of the healing rate (relative frequency of ulcers healed in time units) of severe pressure 
ulcers in the resin salve group and in the control group (hydrofiber dressing with or without silver (Ag+)) 
in the randomized patient trial.
Secondary outcomes measures: During the 6-month treatment period, only one 
ulcer (6% of all ulcers) was not healed in the resin group. Correspondingly, in the 
control treatment group, six ulcers (55% of all ulcers) were not healed. One ulcer 
(9%) in the control group became worse. 
At baseline, 10 different bacterial strains were cultured in both study groups. 
One isolate in one patient in the resin group and one in the control group was the 
MRSA bacterium. In both cases the culture was negative for MRSA one month later. 
Staphylococcus aureus bacteria seemed to be more susceptible to eradication with 
the resin salve than with the control treatment.
Dropout analysis: There were eight (8 of 21; 38%) dropout patients in the 
resin group, and seven (7 of 16; 44%) in the control group (Fig. 7). Reasons for 
the dropouts in the resin group were three deaths, two admissions for operative 
treatment, one allergic skin reaction, one misdiagnosis and one patient-related 
refusal without any specific reason. The reasons for dropouts in the control group 
were four deaths, two patient-based refusals without any specific reasons and one 
patient-related refusal because of the randomization to the control group that the 
patient did not accept, and therefore, finally refused. 
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4.4.2  AN OBSERVATIONAL CLINICAL COHORT STUDy IN PATIENTS WITH 
CHRONIC SURgICAL WOUND (paper VI)
The healing rate of chronic, complicated surgical wounds was 100% (23/23) among 
patients who received the resin salve treatment. There were no dropouts. The average 
healing time was 43±24 days. Immobilization, use of immunosuppressive regimen, 
length and depth of the wound were independent factors of the healing time in 
multivariate regression analyses (Table 3). The wound length was an independent 
factor of the healing time in the multivariate regression analysis. Mathematically 
and theoretically, the wound healed a mean of 2 mm per day, indicating, for exam-
ple, that the healing time was 10 days on average in wounds that were 2 cm long.
No conspicuous or unusual clinical observations were seen in the patients who 
received the resin salve treatment suggesting that the compliance and feasibility 
were good. Clinical worsening (e.g., increase in size or change in appearances of 
the wound) was not observed in any of the patients. 
Examples of the cases with chronic surgical wounds before and after treatment 
with the coniferous resin salve are presented in Fig. 9 and 10. An additional ex-
ample of a case with a chronic, certainly “sterile” surgical wound before and after 
treatment with coniferous resin salve is presented in Fig. 11. 
Covariate R2 P value
      Univariate analysis
Immobilization 0.375 0.001
Corticosteroids or immunosuppressive agents 0.295 0.004
Wound size
deapth 0.351 0.002
length 0.271 0.016
width 0.0 NS
area 0.109 NS
Age 0.093 NS
Sex 0.0 NS
Infection (positive culture) 0.0 NS
Diabetes or smoking 0.0 NS
    Multivariate analysis
Model including all above variates 0.679 0.001
Wound length 0.001
Corticosteroids or immunosupressive agents 0.014
Immobilization 0.041
Others NS
Table 3 table of results of the univariate and multivariate analyses, and of the influence of selected variables 
on the healing time of chronic surgical wounds in 23 patients. Linear regression analysis. All significant 
variables associated positively with the healing time.
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Figure 9 A 50 year old woman with rheumatoid arthritis for 30 years. she received methotrexate, hydrox-
ykloroquine, folic acid and paracetamol medication. After arthrotomy of the left knee, she got a complicated 
surgical chronic wound, which was treated with the coniferous resin salve. Photograph a) at the beginning 
of the treatment b) in 20 days c) in 49 days when the wound was healed.
a)
b)
c)
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Figure 10 A 61 year old male with psoriatic arthritis, treated with methotrexate. After arthrodesis of the 
right ankle with an intramedullary nail, he got a complicated surgical chronic wound on the medial side 
of the lower leg extending to the bone. the wound was treated with coniferous resin salve. Photograph 
a) at the beginning of the treatment b) at 13 days representing granulation tissue on the wound base c) 
at 84 days when the wound was healed with only a small ulcer remnant in the center.
a)
b)
c)
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4.4.3  CALCULATION OF THE DIRECT COSTS OF THE PHARMACEUTICAL  
 MATERIALS (paper VI)
Analysis of the direct costs of the pharmaceutical materials in the resin salve treat-
ment was performed for the 23 patients in the observational cohort study on chronic 
surgical wounds (paper VI). The costs were first assessed in every patient separately, 
after which the mean costs ±SD were calculated. A flowchart of the parameters 
taken into account in this assessment is presented in Fig. 12.
In the beginning of the study, the average wound area was 424 mm2 and the 
amount of resin salve needed for the treatment of a wound of such a size was 
empirically assessed (measured) to be 0.4 g per day. A salve tube of 20 g was cor-
respondingly assessed to be sufficient for 50 days in patients with a wound of the 
average size (424 mm2). Based on these estimations and by taking the consumer 
prices into account, regarding need and package sizes of the salve and accessories, 
the total mean costs of the resin salve treatment per patient during a treatment 
period of 43 days were 45 ±26 €, ranging from 22 € up to 102 € per patient. The 
average daily costs were 1.2 ±0.5 €, ranging from 0.5 € to 2.2 € per day.
Figure 11 An 81 years old male with prostate cancer. Fasciectomy was performed on the right hand due 
to severe dupuytren`s contracture (palmar fibromatosis) affecting the fourth and fifth finger. the wound 
didn’t heal because of tension and wound edge necrosis. no clinical or microbiological evidence of infection 
was found. the chronic wound was treated with coniferous resin salve. Photographs A) at the beginning 
of the treatment B) at 22 days when the wound was healed.
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Figure 12 the flow chart on analysis and parameters taken into account in assessment of the direct costs 
of the pharmaceutical materials in the observational trial, for 23 patients with a chronic surgical wound 
(paper Vi).
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5. DISCUSSION
5.1 gENERAL DISCUSSION
Although the microbiological studies gave somewhat controversial results, the pre-
dominant antimicrobial property of resin and resin salve was clear. However, owing 
to the small number micro-organisms tested generalizations cannot be fully justified. 
Our studies indicate that resin and resin salve seem to have a broad antimicrobial 
property, against both Gram-positive and Gram-negative bacteria. The morpho-
logical and electrophysiological studies were considered to support the microbial 
findings and gave evidence that the antimicrobial actions were unspecific and based 
on destruction of the cell walls and membranes of the micro-organisms.
The clinical studies in this thesis are also small and include a relatively few 
patients so that again generalizations are not defensible. The results suggest, how-
ever, that resin salve treatment tends to have a positive influence on wound heal-
ing, supporting the positive effect of resin salve on skin wounds as experienced in 
traditional medicine for hundreds of years. 
In traditional medicine, resin salves have been used for long periods without 
major problems in tolerability. A predicted side effect of resin salve was resin al-
lergy (colophony allergy / contact dermatitis) that was observed in 2% of the treated 
patients. This finding is in line with the prevalence described in the literature. For 
a more comprehensive picture of the safety of resin salve treatment, larger clinical 
trials are needed. 
5.2 MICROBIOLOgy 
The microbiological observations in this study project show that the coniferous resin 
and the salve manufactured from this resin are strongly antimicrobial against a wide 
range of microbes including both Gram-positive (e.g., S. aureus, MRSA, B. subtilis) 
and Gram-negative bacteria (e.g., E. coli, P. aeruginosa). They are also antifungal 
against yeasts, like C. albicans, and against the most common dermatophytic fungi 
(genus Trichophyton). These observations are in line with those reported in the 
previous and in some recent investigations (Söderberg et al. 1991, Cowan 1999, 
Savluchinske-Feio et al. 1999, Savluchinske-Feio et al. 2007, Wang et al. 2012). 
The agar diffusion test and the European Pharmacopoeia challenge test pro-
vided markedly controversial results regarding the sensitivity of the different species 
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of microbes to coniferous resin. In the agar diffusion tests, coniferous resin was 
antibacterial against all Gram-positive bacteria tested, like S. aureus and MRSA, 
S. epidermidis, E faecalis, S agalactiae, but not, or in lesser extent only, against 
the Gram-negative bacteria. In the challenge study, on the other hand, the resin 
was bactericidal also against the Gram-negative bacteria. In the agar diffusion test, 
resin was not antifungal against the C. albicans yeast whereas the resin was anti-
fungal against C. albicans in the challenge tests. Several explanations are possible 
for these controversies regarding the sensitivity of bacteria and fungi in different 
tests, to the resin.  
Firstly, the antimicrobial susceptibility tests on agar plates may not always be 
fully sensitive and will occasionally give false negative results due to methodologi-
cal problems (Woolfrey et al. 1978; Catry et al. 2007). Secondly, the agar diffusion 
test is likely dependent on the water solubility and on the diffusion and dilution 
of the test substances in the aqueous agar medium. Most of the resin acids are 
poorly water soluble, and therefore may diffuse poorly in sufficient antimicrobial 
concentrations in the agar. Subsequently, the susceptibility of the microbe to the 
resin may be exhibited in agar diffusion tests only for the micro-organisms with the 
highest sensitivity. Since the resin sensitivity of Gram-positive and Gram-negative 
bacteria was different, the observations also indicate that the microbes genuinely 
vary markedly in their antimicrobial sensitivity to the coniferous resin.
In the challenge tests, the microbes are directly exposed to the resin in highest 
possible resin concentration. Therefore in this test, the antimicrobial actions may 
not be solely dependent of diffusion and dilution of resin or resin acids in the test 
medium. This may mean that antimicrobial effectiveness of the poorly water soluble 
coniferous resin against even the most resistant microbes is seen when the resin 
concentration is high enough. The threshold concentration of the resin in a salve 
for it to act microbicidally against most of the bacteria in a liquid physiological 
culture media was observed to be approximately 1% (w/w).
The bacteriostatic minimal inhibitory concentrations (MIC) of the resin were 
tested for Gram-positive bacteria (S. aureus, S. epidermidis, E. faecalis, St. pyo-
genes, and St. agalactiae) in the Mueller-Hinton medium. The MIC values obtained 
were 0.2―0.4% (w/v) that roughly correspond to resin acid concentrations of 2―4 
mg resin in 1 g of the medium. In GLC analyses, the resin acid concentration in 
acetone extracts of the 10% resin salve was around 25 mg in 1 g of salve, suggest-
ing that the concentration of the resin acids in 10% resin salve exceed manyfold 
the MIC values required for the antimicrobial influences in general. In challenge 
tests, the microbicidal effect (no regrowth of microbes) was obtained against all 
bacteria tested, both against Gram-positives and Gram-negatives, or C. albicans, 
with 10% resin salve in 4―7 days.
The MIC estimates obtained in our study represent the minimal concentra-
tions of the purified crude spruce resin in the agar but these MIC values are not 
equivalent to the concentrations of the antimicrobial resin acids dissolving from 
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resin into the water phase of the agar. Natural resins and rosin are slightly water 
soluble. According to the published data, the water solubility of resin acids is vari-
able and the maximal water solubility of resin acids has been reported to be around 
1―5 ppm (parts-per-million); dehydroabietic acid has the highest solubility (Peng 
et al. 2000). Considering that the MIC value of the purified spruce resin is between 
100―1 000 ppm (concentration of purified crude resin in salve or agar 0.1―1% 
(w/w)), and that the concentration of the resin acids in the aquatic agar would be 
1―5 ppm, only a very small proportion of the resin (resin acids) is dissolved from 
the resin into the aquatic phase of the medium or the tissues. Nevertheless this 
small proportion (approximately one millionth of the concentration in MIC values), 
is capable of exerting an antimicrobial effect. 
The exact mechanisms of the antimicrobial actions of the coniferous resin or 
resin acids against the microbes are not known. These mechanisms cannot be, 
however, specific since practically all micro-organisms seem to be more or less 
sensitive to resin, either in the agar diffusion, liquid media, or in the challenge 
tests. It is considered that the terpenes in general, a subgroup of the chemicals the 
resin acids also belong to, have direct toxic influences on the microbial cell walls 
and membranes (Sikkema et al. 1995, Wang et al. 2012). This explanation is sup-
ported by the present morphological and electrophysiological observations. In our 
study, the destruction as seen in the cell walls of both bacteria and fungi, suggest-
ing also that this damage is diffuse injury, and is not species dependent as is often 
the case with the antibiotics.
The resin acids are considered to be the major antimicrobial factor of the conif-
erous resin as seen in the literature (Söderberg et al. 1991, Savluchinske-Feio et al. 
1999, Wang et al. 2012). In our study and in concordance with earlier observations, 
abietic acid showed identical antimicrobial influences to those of the resin or resin 
salve (Söderberg et al. 1990, Söderberg et al. 1991, Smith et al. 2005). Lignans and 
coumaric acid are, on the other hand, compounds with anti-inflammatory and an-
tioxidative properties (Kangas et al. 2002, Willför et al. 2003, Miyake et al. 2005). 
There are some resemblances in biological actions between resin and ionic silver. 
Silver ions damage cell walls and cytoplasmic membranes, this damage appearing, 
however, more slowly than with the common chemical disinfectants like sodium 
hypochlorite or phenols (Chamakura et al. 2011, Li et al. 2011). The antimicrobial 
actions of coniferous resin and ionic silver differ from those of medical honey, the 
actions of which are obviously due to the acidity, hydrogen peroxide, an osmotic 
effect, or to the presence of unidentified compounds in the medical honey (Al-Waili 
et al. 2011).
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5.3 MORPHOLOgy AND ELECTROPHySIOLOgy 
Our electron microscopical investigations indicated that the exposure of the cultures 
of S. aureus to spruce resin, resin salve, or purified abietic acid resulted in changes 
in structure and function of the microbial cell wall, indicating that the injuries of 
cell wall and membranes are the cause of the microbicidal actions of the resins. 
It was shown by our electron microscopical observations that the exposure to 
resin or to 10% (w/w) resin salve for 18 h thickened the bacterial cell walls and 
increased the cell adherence. The exposure of the S. aureus cultures to resin in a 
concentration of 0.1% (w/v) increased the proportion of branched fatty acids in 
cell wall lipids, and the exposure of the microbes to resin or abietic acid for 90 
min dissipated the membrane potential in bacterial cells. Since S. aureus cultures 
recovered even after long-term (3 days) contact with resin in the ordinary micro-
biological cultures, this electrophysiological dissipation of the membrane potentials 
may not result from simple cell death, but may, instead, be caused by failures in 
the proton-motive force across the cell membranes. The transmembrane potential 
may partially disappear even though the bacteria do not immediately die. Based on 
these observations, one may assume that the antimicrobial action of the coniferous 
resin against the microbes is more detergent-like and bacteriostatic than simple 
and fast necrotic killing of the cells.
Some resin acids (e.g., dehydroabietic acid and its hydroxylated derivates in 
particular) are compounds that can dissolve in small amounts in water. In GC/
MS analysis of methylene chloride extracts of resin – water dispersions, dehy-
droabietic acid and its hydroxylated derivates (7α - or 7β -hydroxydehydroabietic 
acid 15-hydroxydehydroabietic acid, 7α,15- or 7β,15-dihydroxydehydroabietic acid) 
dissolve in water in concentrations of 0.5 ― 16 mg/L (unpublished observations). 
At physiological pH in an aquatic milieu, these compounds may be in both pro-
tonated and non-protonated form. The non-protonated forms may act as proton 
acceptors. The protonation of the resin acids may increase their fat solubility, and 
it can also enhance the protonophoric transport of H- ions across the cell mem-
brane. The enhanced ionophoric transport of protons may interfere with the proton 
transport in the membrane-bound ATPase, resulting in uncoupling of the oxidative 
phosphorylation. Subsequently, the cell metabolism may cease and the supply of 
energy may be lost (Wikström 2009). 
Our observations of an increase in the proportion of the branched-chain fatty 
acids in S. aureus lipids after exposure to the resin or abietic acid indicate that the 
resin or resin acids do not act only as simple protonophores. The structural altera-
tions of the cell wall macromolecules may change the permeability and fluidity of 
the cell membrane and cell wall, and may, thereby, also disturb the normal physi-
ological functions of the cell walls and cell membranes.
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5.4 CLINICAL TRIALS
Our randomized controlled trial in patients with pressure ulcers (RCT, paper V) 
and the observational study in a cohort of patients with chronic surgical wounds 
(paper VI) are, to the author´s knowledge, the first studies on the clinical efficacy 
of coniferous resin salve in skin wounds and ulcers. There are no earlier (before 
2008) scientific publications in the MEDLINE database available with key words 
“resin salve and clinical trial” or “resin and skin ulcer”.
The RCT documented a significantly higher healing rate of severe pressure ul-
cers with the coniferous resin salve with ordinary gauze dressings compared to the 
healing rate of pressure ulcers with the nonadhesive hydrofiber dressings. The ulcer 
healing rate was significantly (P<0.05) higher in the resin salve treatment group 
than in the control group, in both the per protocol analysis, and in the ITT analysis. 
In a systematic review of the Royal College of Nursing and National Institute for 
Health and Clinical Excellence (NICE) in 2005, modern dressings like hydrofibers 
or hydrocolloids, instead of saline gauzes, paraffin gauze or simple dressing pads, 
are recommended as treatment tools in the pressure ulcers. The hydrofiber and 
hydrocolloid dressings represent advanced technology and have been demonstrated 
to improve objectively the healing of pressure ulcers as compared with ordinary 
saline gauze treatment (Ontario Health Technology Advisory Committee Meta-
analysis 2009). The hydrocolloid dressings are considered to create the optimum 
healing environment (NICE 2005). Since the resin salve with ordinary gauzes in 
the present trial gave better treatment results than the modern hydrofiber dress-
ings, one may conclude that the superiority of the resin salve in pressure ulcers is 
due to the salve itself, not due to any additional facilities or dressings.
In previous studies, the treatment of pressure ulcers with the hydrofiber dress-
ings for 6 months have been reported to result in total healing in 55 % of cases in 
general and in 89% of cases with stage II ulcers  (Alm et al. 1989, Xakellis et al. 
1992). In the present RCT, the treatment of stage II-IV pressure ulcers with hy-
drofiber dressings resulted (in the per protocol analysis) in healing of the ulcer in 
44 % of the patients (95%CI:12–77%; 4 of 9 patients). This is a healing rate that is 
in line with the earlier published data.  
In our RCT on pressure ulcers, the patients with an infected ulcer in the con-
trol arm received hydrofiber dressings impregnated with silver (Ag+). Silver has 
antimicrobial properties but the superiority of the silver impregnated dressings 
over those without silver is controversial and based on very few investigations of 
moderate quality only (Rosén 2010). In a multicenter RCT on leg ulcers, 60% and 
57% of ulcers healed in 12 weeks using the hydrocolloid dressings with silver and 
without silver, respectively (Michaels et al. 2009). 
Silver has clear antibacterial influences and reduces the number of the micro-
organisms in microbial cultures in in vitro experiments, the bactericidal effect re-
58
DISCUSSION
sulting from the damage to cell wall and cytoplasmic membranes (Ivanova et al. 
2011, Monteiro et al. 2011, Percival et al. 2011). Studies on the antibacterial influ-
ences of ionic silver at tissue level, in vivo, are, however, scanty (Rosén 2010). In 
one available study on leg ulcers, the silver impregnated dressings did reduce the 
count of bacteria in the wound (Sibbald et al. 2007). In our RCT, both the resin 
salve treatment and the hydrofiber dressings with or without silver resulted in 
microbiological clearance of pressure ulcers, this clearance taking place, however, 
somewhat faster with the resin salve than with the hydrofiber dressings.
In designing the study protocol of our RCT, the treatment was expected to take 
months because of the advanced age of the patients, and because of the large size 
and long clinical history of the pressure ulcers in the patients. The duration of the 
study was designed to last up to 6 months, and the a priori calculations of power 
(above 70%) indicated that approximately 20 cases had to be included in both study 
arms by assuming that the resin salve treatment would result in ulcer healing 25% 
more often than in the control treatment. It was finally observed that all ulcers in 
all patients in the resin group, except one ulcer in one patient, healed during this 6 
month treatment period, and that the resin salve treatment was significantly better 
than the control treatment, the power of the study being 73%.
The observational clinical cohort study (paper VI) was carried out to investigate 
the feasibility and safety aspects of the resin salve treatment in complicated and 
chronic surgical wounds. Even though the trial did not include control cases, it is 
noteworthy that all consecutive wounds in patients admitted to the trial from two 
centers, with the length of the open wound varying between 5 mm and 60 mm (mean 
29 ±19 mm), healed in a reasonable time, 43 days on average (range: 10―87 days), 
without any clinical drawbacks. This wound healing time in the present investiga-
tion was somewhat shorter than the healing time reported in two earlier similar 
studies (Shealy et al. 2006, Ubbink et al. 2008). For comparison, it was reported 
in a recently published RCT on chronic venous leg ulcers using modern hydrofiber 
dressings with silver (Ag+), progression of wound healing occured in 52―67% of 
the cases in 8 weeks (Harding et al. 2011).
There are only few high quality studies in the literature on the efficacy of vari-
ous conservative (non-surgical and non-device based) topical treatment options 
of chronic surgical wounds. In a recent Cochrane Library systematic review and 
meta-analysis, 13 RCTs on the efficacy of various dressings or topical agents in 
postoperative chronic wounds were analyzed (Vermeulen et al. 2004). The results 
published in these studies were concluded to be non-comparable and unreliable 
because of the many inconsistencies and flaws. Exceptions were a small study on 
Aloe vera and one study on plaster cast applied to an amputation stump. Otherwise, 
there were no statistically significant differences in the healing rates of the chronic 
surgical wounds between the various treatment tools applied (e.g., gauze, modern 
hydrofiber and hydrocolloid dressings, foams, alginate, etc.; 11 trials) (Vermeulen 
et al. 2004). In a RCT in patients with chronic surgical and traumatic wounds, 
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treatment with hydrofiber dressings with silver for 2 weeks was not significantly 
better than treatment with iodine gauzes, the hydrofiber treatment resulting in the 
wound healing in 23% of the patients (Jurczak et al. 2007). In another systematic 
review, the modern hydrogel dressings were recommended for wound debridement 
only (Vaneau et al. 2007). In a British review on four RCTs including altogether 
221 patients, by comparing the hydrocolloid dressings with the saline gauzes, the 
odds of wound healing in 6 weeks to 6 months varied from 1 to 11 in favor to the 
hydrocolloids (NICE 2005). In the present RCT, the OR (odds ratio) for ulcer heal-
ing in 6 months was 30 (95%CI: 4―218) in favor of the resin salve as compared 
with the hydrofiber dressings. 
In the multivariate linear regression analysis of the data from the observational 
cohort study on chronic surgical wounds, the wound length was found to be nega-
tively correlated with the healing time and to be an independent parameter for pre-
dicting wound healing. Under resin salve treatment, the re-epithelization (healing) 
of wounds occurred at 2 millimeters per treatment-day, on average, according to 
the regression analysis. This observation may mean that, if the wound healing takes 
place per primam with the resin salve, the surgical complicated wound heals (re-
epithelializes) along the longitudinal axis by one millimeter per day at both wound 
ends, the late remnants of wound remaining in the wound center before the final 
closure of the wound (Fig. 10). This is certainly a simplification and a theoretical 
model only. Wound healing in clinical practice is more complicated and also depend-
ent on factors other than the wound length, e.g. on contraction of the wound edges.
5.4.1   LIMITATIONS OF THE PRESENT CLINICAL TRIALS
There are several limitations in the present clinical investigations. Firstly, the exact 
knowledge of the past history of patients in the RCT was not available and, there-
fore, the disease history could not be used as an objective parameter. In an earlier 
investigation in Finland on chronic skin wounds and ulcers among the geriatric ward 
patients, the disease history of ulcers varied from 3 months to 4 years indicating 
that the pressure ulcer is an extremely long-lasting disease (Eriksson et al. 1999). 
On the other hand, the baseline characteristics (length, width and depth) of the 
wounds were known and noted in all patients in the observational cohort study. In 
these patients, the resin salve treatment was, however, instituted as a primary treat-
ment method when the wound was observed and classified chronic and complicated 
(wound open 2 weeks after the elective operation). Therefore, the past history was 
considered irrelevant and need not be taken into account. 
Secondly, in our RCT, the requirement of blind outcome measures, or conceal-
ment in the allocation, could not be fulfilled because of the characteristic physical 
features (color, smell, etc.) of the resin salves. The present RCT was a multicenter 
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study (11 health centers) which may reduce the bias caused by possible preconcep-
tions in clinical assessments or in patient inclusions.
Thirdly, the number of patients in both trials was relatively small, particularly 
in the trial on pressure ulcers (RCT; paper V), but corresponds to the number of 
patients in two previous RCTs on skin wounds in the available literature (Burke 
et al. 1998, Griffiths et al. 2001). Long-continued therapy (6 months) is laborious, 
expensive and difficult to carry out which forces limitation of the patient number. 
Patients are, in addition, old and, due to natural deaths, the frequency of drop outs 
is high which handicaps the final conclusions.
Fourthly, there are no accepted standards (“gold standard”) in wound care in 
the cases outside the scope of the surgical procedures (Gottrup et al. 2010). This 
makes the selection of reference treatment difficult. The skin wounds and ulcers 
are treated with manifold of tools and with varying methods, of which there are 
not much evidence of effectiveness or data of the costs (Iivanainen et al. 2011). In 
the present RCT, the resin salve treatment was to be compared with the hydrofiber 
dressing (with or without silver; Ag+) treatment. These dressings are widely used 
in Finland and are considered to be capable, corresponding with the antimicrobial 
activity of the resin salve, of absorbing bacteria even though the evidence of this 
antimicrobial ability is sparse (Barnea et al. 2010). In Sweden, more than 60% of 
the health care centers practicing wound care use the silver (Ag+) impregnated 
hydrofiber dressings (Rosen 2010). At the time of institution of the present RCT 
(in 2008), the hydrofiber bandage was a generally accepted and widely used treat-
ment option, and was, therefore, chosen as a reference (control) treatment option.
5.4.2  DIRECT PHARMACEUTICAL COSTS
The consumer prices, the product sizes and the daily consumption of the wound 
care products vary greatly which makes it difficult to compare the costs between 
the different treatment options. To achieve as objective estimation of the expenses 
of the pharmaceutical material as possible, the costs of these consumables were 
calculated and estimated individually in every 23 patient in the observational cohort 
study (paper VI). 
The costs of the occlusive and gauze-based dressings commonly used in the 
wound care have been investigated earlier in one study (Ubbink et al. 2008). In this 
investigation, the overall costs of the occlusive and gauze dressings per treatment day 
and per patient were 7.48 €, and 3.98 €, respectively. In our study, the direct costs 
of the pharmaceutical materials in the resin salve treatment in the present study 
was 1.2 ± 0.5 € per patient and treatment day. It seems that these daily costs of the 
resin salve treatment are considerably lower than those with, e.g., medical honey 
or sodium carboxymethylcellulose hydrocolloid polymer or hydrofiber dressings. 
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The skin substitute products from cell culture or other special techniques mark-
edly exceed the consumable costs of the ordinary topical wound care items. The 
costs of the skin substituent was estimated to be over 5,000 € per treated patient 
in Switzerland (Ortega-Zilic et al. 2010). In a patient case from USA, the total costs 
of the treatment of stage III-IV ischial pressure ulcer for twelve months with wet-
to-dry dressings and for 15 months with biological dressings and negative pres-
sure wound therapy was 183,000 € when extrapolated from the insurance records 
(Schessel et al. 2012). In these perspectives, the modern dressing therapies, and 
particularly the resin salve, seem to be inexpensive treatment options which even 
allow the ulcer care at home.
No analyses on expenses were done in the present RCT. The daily cost of the 
pharmaceutical consumables in the resin salve treatment is probably quite similar 
in the pressure ulcer patients and those with chronic surgical wounds. Therefore, 
it is possible that the direct cost of the pharmaceutical materials in the treatment 
of pressure ulcers for up to 6 months is cheaper with the resin salve than with 
the hydrofiber dressings. One may extrapolate that the cost of the consumables, 
without labour expenses, in the treatment of one pressure ulcer for 6 months was 
around 250 €. In Germany, the cost of treatment of pressure ulcers for 2 months in 
a hospital setting was estimated to be more than 6,000 € per patient (Assadian et 
al. 2011). In a multi-centre study of economics over a period of 8 months in three 
community hospitals in Germany, the mean cost of treatment of one leg ulcer was 
1,342 € (48 € per day), of which the share of the cost attributable to consumables 
was 458 € (34% of the total cost) (Assadian et al. 2011).
5.5 ALLERgy, SIDE EFFECTS AND SAFETy ASPECTS 
Resins and rosins occur as ingredients in thousands of products of our everyday 
life without major health problems (Färm et al. 1994, Krob et al. 2004). In the 
past, coniferous resins have been used as chewing gums and were even ingested 
by people and animals (Metsälä 2001).
Allergy to natural resins and rosins (colophony allergy) is, however, a well known 
side effect of resin salve therapy, and is a result of the exposure of the sensitized 
patients to the resin acids (Färm 1998). The allergy risk may vary between differ-
ent types of rosin products and between different resin acids. Colophony allergy is 
relative rare, but seems to occur among people in patch tests in frequencies that 
resemble the prevalence rates of allergy to neomycin or lanolin (Uter et al. 2002, 
Bajaj et al. 2007, Dotterud et al. 2007, Lindberg et al. 2007). 
In objective studies, colophony allergy appears in 1―3% of people in general 
(Färm 1998, Downs et al. 1999). In Sweden, approximately 5% of patients patch 
tested for dermatitis symptoms in a special dermatology clinic showed allergy to 
colophony (Färm 1998). In our clinical studys (papers V and VI) the total prevalence 
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rate of the allergic contact dermatitis to resin was 2% (95%CI: 0-5%). However, the 
small number of patients in the trials have to be taken into account when making 
conclusions.
The tars that are manufactured from the coniferous resins and rosins by heat 
(pyrolysis), and by distillation, contain carcinogenic compounds (Roelofzen et al. 
2007). For this reason the use of tars is prohibited in the EU and tar is considered 
toxic or carcinogenic. Coal tar was commonly used in the past as a treatment option 
for psoriasis in the dermatology clinics (Roelofzen et al. 2007). Manufacturing of 
salve including coniferous resins without heating, they do not contain carcinogens 
as demonstrated by the present negative Ames tests. Neither are the purified resin 
acids mutagenic (Nestmann et al. 1979). Both the resin acids and rosins in high 
concentrations are, on the other hand, toxic to some aquatic organisms, as is the 
case with pulp and paper mill effluents (Oikari et al. 1982, Peng et al. 2000). Ac-
cordingly, the 10% resin salve was cytotoxic against mouse fibroblasts in the present 
in vitro cytotoxicity tests. However, the in vitro toxicity was strongly concentration 
dependent. The cytotoxicity diminished to mild when the salve was diluted to 2.5% 
(1+3) in its resin content. When used in vivo for skin wounds and ulcers, the salve 
with 10% resin content did not show any adverse effects, indicating that the resin 
components dissolved in water and tissue fluids are quickly diluted to levels that 
cause no significant toxic effects.
5.6 WHy DOES THE CONIFEROUS RESIN PROMOTE  
 WOUND HEALINg? 
Although our “resin salve project” gives evidence that coniferous resin salve im-
proves the healing of skin wounds and ulcers, it does not provide ultimate answers 
as to why this happens. 
The optimal wound care product should include a wide-range antimicrobial 
property, be able to enhance and stimulate epithelialization and the healing pro-
cesses in a chronic wound, and be inexpensive and safe. Resin salve may fulfill 
many of these requirements. The salve (and resin) is antimicrobial against a very 
large range of microbes, and this antimicrobial action certainly is one of the critical 
factors in healing wounds (Clark 1996, Broughton et al. 2006, Velnar et al. 2009). 
Furthermore, it is not expected that the salve induces resistant microbial strains 
as is the case with antibiotics. In addition, the salve also seems to promote the 
healing of ulcers and wounds that are not clinically infected, suggesting that in the 
wound care the salve also acts by mechanisms other than by being antimicrobial. 
The beneficial effects of coniferous resin in wound care must partly be linked 
with the physiological processes of wound healing. This conclusion is supported 
particularly by our observation in the RCT that pressure ulcers without infection 
also healed with the resin salve. Coniferous resins and the resin salve contain cou-
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maric acid (hydroxycinnamic acid) and lignans. Both of these compounds are po-
tentially biologically active and may promote the repair processes (Ferguson et al. 
2005, During et al. 2012). 
The lignans are “phytoestrogens” which are, after ingestion, by intestinal bacteria 
metabolized to compounds (enterolactone and enterodiol) with hormone-like prop-
erties (Adlercreutz 2007). Such hormonally active metabolites may also therefore 
be formed from the lignans in skin wounds by actions of the skin bacteria. This 
may further result in enhancements of the molecular and cellular mechanisms in 
wound repair: lignans or their active derivates may enhance the synthesis of col-
lagen and hyaluronic acid, or stimulate the re-epithelialization. Such effects would 
resemble the actions of the estrogen hormones on the aging skin (Jackson et al. 
2011, Shu et al. 2011). 
Lignans and coumaric acid (hydroxycinnamic acid) are polyphenols and have 
antioxidative and anti-inflammatory properties (Ferguson 2001, Kangas et al. 2002, 
Dragsted 2003, Ferguson et al. 2005, Saleem et al. 2005, Adlercreutz 2007, Li et 
al. 2007, Cosentino et al. 2010, Maurya et al. 2010). Both of these properties are 
likely to affect the cellular and molecular processes in wound repair. Lignans and 
coumaric acid may enhance wound healing, e.g., by inhibiting the release of free 
radicals, reactive nitrogen species (NO), and by inhibiting proteinase expression 
in the  PMNs, by improving the wound debridement and by reducing, thereby, 
growth factor inhibitions (Salim 1991, Cosentino et al. 2010). Anti-inflammatory 
agents are reported to enhance wound re-epithelialization, to improve macrophage 
infiltration and to reduce PMN activity in experimental wound repair models, and 
they may also diminish wound pain (Jorgensen et al. 2008, McLennan et al. 2008). 
By possessing anti-inflammatory properties due to the presence of coumaric acids 
and lignans in high quantity, the coniferous resin and resin salve may enhance the 
proliferation of fibroblasts and promote the synthesis of fibronectin, collagen I and 
III, all which are impaired in chronic wounds (Mariggio et al. 2009).
In contrast to the resin acids, coumaric acid and the lignans are water soluble 
and can reach the tissues in concentrations high enough to arouse significant bio-
logical influences. All these possible mechanisms and actions of the lignans and 
coumaric acid remain, however, speculative.
5.7 CHEMICAL COMPOSITION OF SPRUCE RESIN 
Coniferous callus resin is a complex mixture of various compounds, of which many 
may be biologically active. In the chemical analysis of natural resins from varying 
sources, the resin acids (dehydroabietic, abietic, neoabietic, levopimaric, pimaric, 
palustric, isopimaric acids, etc.) were observed to be the major components in ac-
etone extracts of the coniferous callus resins, in addition to lignans (lariciresinol, 
pinoresinol and matairesinol, etc.) and coumaric acid (Holmbom et al. 2008). In 
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line with these observations, our GLC/MS analyses indicated that the diterpenoid 
resin acids and lignans together are the major components and occur in 10% resin 
salve (acetone extracts) in a concentration of more than 30 mg/g (w/w). Accordingly, 
the concentration of resin acids and lignans together is at least 300 mg/g (w/w) 
in the crude purified spruce resin. The high quantity of the coumaric acid was a 
surprise. GLC/MS analyses of the acetone extracts of the resin salves showed that 
the concentration of coumaric acid in 10% resin salve was around 4 mg/g (w/w), 
and in crude coniferous spruce resin 40 mg/g (w/w), respectively. 
The total mass of resin acids, lignans and coumaric acid was less than half of 
the total mass of the crude resin. This is in some controversy with earlier analyses 
which indicate that only the resin acids would form 70% of the total resin mass 
(Langenheim 2003, Holmbom et al. 2008). The discrepancies may be due to meth-
odological differences, and depend on how the extractions are carried out and also 
depend on the kind of resin analyzed (pathological vs. physiological resin). Other 
components than resin acids, such as fatty acids and uncharacterized terpenes or 
terpenoids, may vary in concentration in resins of different origin or type. In our 
analysis, however, the concentrations of resins acids, coumaric acid and lignans 
remain similar and stable in different samples of coniferous “callus” resin from 
Norway spruce collected in Western Lapland in Finland. In addition, the concentra-
tions of these compounds remained stable and unchanged over many years in the 
resin salves preserved at room temperature, or even when preserved in stringent 
environmental conditions (6 months in 40oC).
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6. CONCLUSIONS
The author´ s answers to the study objectives are:
1. The pure coniferous resin from Norway spruce and 10% resin salve manu-
factured from this resin are antimicrobial against a wide range of bacteria, 
and fungi.
2. The antimicrobial action is unspecific and results in damage to the cell mem-
branes and walls in the micro-organisms. This damage results in structural 
and electrophysiological changes in the cell walls and membrane.
3. Allergic reactions are rare and occur in 2% of patients with long-term use 
(weeks or months). Natural coniferous resin is not mutagenic in Ames tests. 
Salve is negligibly irritating in the rabbit skin irritation test and is cytotoxic 
against mouse fibroblasts in the in vitro cytotoxicity tests
4. Natural coniferous resin salve is a promising treatment option in the local 
treatment of pressure ulcers and chronic surgical wounds. It promotes the 
healing of advanced, severe pressure ulcers more effectively than standard 
treatment with hydrofiber dressings. In chronic surgical wounds, resin salve 
treatment positively associates with progressive healing of the wound. The 
improvement of skin ulcers and wounds is not limited to the healing of 
infected wounds only, suggesting that the resin has positive influences on 
mechanisms that play a role in wound repair. 
5. The direct costs of the pharmaceutical materials (resin salve and accessories) 
in resin salve treatment are low: the mean cost per patient per treatment 
day is 1.2 ±0.5 €.
6.1 ASPECTS FOR THE FUTURE
Chronic skin wounds and ulcers are a common and increasing problem in our so-
ciety. The prevalence accumulates with age, their treatment is laborious and costly 
and the current practices are largely based on subjective impressions of efficacy. 
In wound infections multiresistance of micro-organisms is an increasing problem. 
Therefore, new therapeutic options and practices are needed. Resin salve may pro-
vide some opportunities in this respect but more controlled studies, knowledge and 
experience are required to confirm the safety and efficacy of resin salve. 
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TIIVISTELMÄ
7. TIIVISTELMÄ
Sipponen, Arno.  Pihkasalva, vanha mutta edelleen tehokas hoito 
  kroonisiin haavoihin – laboratorio- ja kliininen tutkimus
Ortopedian ja Traumatologian Yksikkö, HYKS, Helsinki, Suomi sekä Päijät-Hämeen 
Keskussairaala, Lahti, Suomi
Havupuun, varsinkin kuusen pihkasta valmistettu kotitekoinen salva on ollut käy-
tössä haavojen ja ihoinfektioiden kansanlääkinnässä vuosisatojen ajan. Kirjoittajan 
omiin positiivisiin empiirisiin havaintoihin perustuen käynnistettiin ”pihkasalva-
projekti”, jonka tarkoituksena oli selvittää (1) kuusen runkopihkan (”calluspihka”; 
resin) ja pihkasalvan antimikrobisia ominaisuuksia käyttäen objektiivisia labora-
toriotutkimusmenetelmiä, sekä (2) tutkia pihkasalvan tehoa, soveltuvuutta ja tur-
vallisuutta haavanhoidossa objektiivisten kliinisten potilastutkimusten perusteella. 
Väitöskirja koostuu neljästä projektiin kuuluvasta mikrobiologisesta tutkimuksesta 
sekä kahdesta kliinisestä potilastutkimuksesta. 
Mikrobiologiset tutkimukset Agar diffuusiotesteissä, European Pharmacopoeia’n 
challenge testeissä ja mikrobien kasvatusnesteissä osoittivat, että kuusen pihka, 
10%:nen pihkasalva ja puhdistettu hartsihappo (abietiinihappo) olivat voimakkaasti 
ja laajakirjoisesti antimikrobisia varsinkin Gram-positiivisia, mutta myös Gram-
negatiivisia bakteereja kohtaan, mukaan lukien metisilliini-resistentti Staphylo-
coccus aureus (MRSA) sekä vankomysiini-resistentti enterokokki (VRE). Pihka ja 
pihkasalva olivat lisäksi vahvasti antifungaalisia yleisimpiä kynsisientä aiheuttavia 
dermatofyyttejä sekä Candida albicans hiivasientä vastaan. Pihkan ja pihkasalvan 
todettiin vaurioittavan mikrobien soluseinämää ja solukalvoa. Pyyhkäisy- sekä lä-
päisyelektronimikroskooppisten tutkimusten perusteella pihkalle tai pihkasalvalle 
altistettujen bakteerisolujen seinämät paksuuntuivat, solut muodostivat ryppäitä ja 
mitoosit keskeytyivät. Staphylococcus aureus bakteereilla tehdyt elektrofysiologiset 
tutkimukset osoittivat, että mikrobien altistaminen kuusen pihkalle tai hartsiha-
polle (abietiinihappo) aiheuttivat solukalvopotentiaalin häviämisen sekä muutoksia 
soluseinämän rasvahappojen haarautumisessa. Todettujen muutosten tulkittiin 
viittaavan siihen, että pihkan antimikrobinen ominaisuus on seurausta mikrobien 
soluseinämään kohdistuvasta vauriosta, jonka vaikutuksesta mikrobisolujen ener-
giatuotanto estyy.
Pihkan turvallisuutta koskevat tutkimukset osoittivat, että pihkalla ja pihka-
salvalla ei ole mutageenisiä ominaisuuksia Ames-testin perusteella eikä 10%:nen 
pihkasalva aiheuta merkittävää ärsytystä (irritaatiota) kanin terveellä iholla tehdys-
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sä kontrolloidussa ja sertifioidussa ärsytystestissä. Sertifioidussa in vitro- testissä 
10%:nen pihkasalva oli fibroblasti- soluviljelmässä sytotoksinen.
Kaasu-neste kromatografia (GLC) sekä massaspektrometritutkimukset osoit-
tivat pihkan ja pihkasalvan (asetoniuutos) sisältävän ainakin kolme biologisesti 
potentiaalista aineryhmää: p-kumarihappo, hartsihapot (abietiinihappo, dehyd-
roabietiinihappo, isopimarihappo, jne.) sekä lignaanit (pinoresinoli, larisiresinoli, 
jne.). Kuusen puhdistetun runkopihkan asetoniuutteessa hartsihappojen ja lig-
naanien kokonaispitoisuus oli keskimäärin 300 mg/g sekä 10 %:ssa pihkasalvassa 
30 mg/g. Pihka sisältää myös rasvahappoja sekä monoterpeenejä, flavonoideja ja 
tanniineja, joiden pitoisuutta tutkimuksessa ei määritetty.
Satunnaistetussa, prospektiivisessa kliinisessä potilastutkimuksessa verrattiin 
perinteisen pihkasalvan tehoa gradus II-IV painehaavaa sairastavilla potilailla 11 
terveyskeskuksen vuodeosastolla. Pihkasalvaa verrattiin hydrofiiberihoitoon (ilman 
hopeaa tai hopean kanssa) 37 potilaalla. Pihkasalvahoito tai vertailuhoito voitiin 
toteuttaa 22 potilaalla 6 kk hoitoperiodin kuluessa. Sekä per protocol että ITT 
(intention-to-treat) analyysien mukaan pihkasalva oli tilastollisesti (P = 0.003; per 
protocol analyysi; parantuneet haavat) vertailuhoitoa merkittävästi tehokkaampi. 
Pihkasalvaryhmässä kaikki haavat paranivat 6 kuukauden hoitojakson aikana yhtä 
haavaa lukuun ottamatta (94% (95%CI 84-100%)). Vertailuryhmässä alle puolet 
(36% (8-65%)) haavoista parani kuuden kuukauden hoitojakson aikana. Pihka-
salvan tehokkuus haavan paranemisessa oli riippumaton siitä oliko haava infek-
toitunut vai ei. 
Toisessa potilastutkimuksessa (observaatiotutkimus) selvitettiin 10%:sen pih-
kasalvan tehokkuutta sekä käytettävyyttä 23 kroonista, komplisoitunutta leikkaus-
haavaa (avoimen haavan pituus 29±19 mm; vaihteluväli 5-60 mm) sairastavalla 
potilaalla kotihoitona/itsehoitona. Kaikki haavat paranivat keskimäärin 43±24 päi-
vässä. Haittavaikutuksia ei todettu ja hoitoa ei jouduttu lopettamaan yhdelläkään 
potilaalla. Laskennallinen haavaan paranemisnopeus (re-epitelisaatio) oli keski-
määrin 2 mm päivässä. 
Potilastutkimukset (satunnaistettu tutkimus ja observaatiotutkimus; per pro-
tocol) kohdistuivat yhteensä 45 potilaaseen, joista yksi (2%; 95%CI: 0-5%) potilas 
satunnaistetussa painehaavatutkimuksessa sai allergisen reaktion (allerginen kon-
taktidermatiitti). Muita allergisia reaktioita tai haittavaikutuksia ei tutkimuksissa 
todettu. Pihkasalvahoidon hoitotarvikkeiden (pihkasalva, sidetaitokset, ym.) hin-
naksi observaatiotutkimuksessa komplisoituneissa leikkaushaavoissa laskettiin 1.2 
€ ±0.5€ per hoitopäivä.
Tutkimukset osoittavat, että kuusen pihkasta valmistettu salva on objektiivisesti 
arvioituna tehokas, halpa ja turvallinen hoito ihohaavoissa. Pihka ja 10%:nen pih-
kasalva, ja niiden sisältämät hartsihapot, ovat laajakirjoisesti antimikrobisia, mutta 
salvan haavojen paranemista nopeuttava vaikutus täytyy johtua potilastutkimusten 
perusteella myös pihkan positiivisesta vaikutuksesta haavan paranemista ohjaaviin 
mekanismeihin, ei pelkästä pihkan antimikrobisesta ominaisuudesta.
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8. ZUSAMMENFASSUNG
Sipponen, Arno.  Harzsalbe, altbewährte und effektive Behandlung 
  chronischer Wunden - Labor- und Klinikstudien
Abteilung für Orthopädie und Traumatologie, Universität von Helsinki, Helsinki, 
Finnland und Päijät-Häme Zentralklinik, Lahti, Finnland
Natürliche Nadelbaumharze und andere terpenische Holzextrakte werden als 
Rohstoffe in verschiedenen Industrieprodukten verarbeitet und in Finnland schon 
seit hunderten von Jahren in der traditionellen Medizin verwendet, vor allem als 
hausgemachte Salben zur Behandlung von Hautverletzungen, chronische Wunden 
und Infektionen. Aufgrund der positiven empirischen Erfahrungen des Autors mit 
Harzsalbe in der Wundpflege wurde das “Harzprojekt” entwickelt, um (1) die anti-
mikrobischen Eigenschaften des Harzes und der Harzsalbe mittels labortechnischer 
Verfahren zu erforschen und (2) die Effizienz, Anwendbarkeit und Sicherheit der 
Harzsalbe zur Wundpflege in objektiven klinischen Studien zu testen. Die Dissertati-
on besteht aus vier mikrobiologischen Untersuchungen und zwei klinischen Studien.
Mikrobiologische Studien mit einem Agardiffusionstest und mit dem Provoka-
tionstest des Europäischen Arzneibuchs (European Pharmacopoeia challenge test) 
zeigten, daß Harz und Harzsalbe starke antimikrobische Eigenschaften gegenüber 
einer Vielzahl von sowohl Gram-positiver, als auch Gram-negativer Bakterien auf-
zeigten, darunter auch das methicillinresistente Staphylococcus aureus (MRSA) und 
die vancomycinresistente Enterococcus (VRE). Das Harz und die Harzsalbe waren 
darüber hinaus antifungal gegenüber den gängigsten Dermatophyten, sowie gegen 
die Candida albicans-Hefepilz. Die antibakterielle Wirkung des Harzes wurde als 
Ergebnis der Zerstörung der bakteriellen Zellwand- und Zellmembranstrukturen 
beobachtet. Laut Beobachtungen durch Scanning- und Transmissionselektronen-
mikroskopie zeigten Mikroben, sowohl Bakterien, wie auch Pilze, die dem Harz 
oder der Harzsalbe ausgesetzt wurden, eine Verdickung der Zellwände, Bildung von 
Zellaggregate und Hemmung von Mitosen. In elektrophysiologischen Experimenten 
mit Staphylococcus aureus verursachte die Aussetzung von Mikroorganismen ge-
genüber Harz und Harzsäure (Abietinsäure) die Auflösung des Zellmembranpo-
tentials und veränderte die Ramifikation von Fettsäuren in den Zellwänden. Aus 
den beobachteten Veränderungen wurde der Schluss gezogen, daß das Harz und 
die Harzsalbe durch den Schaden an den Zellmembranfunktionen Einfluß auf das 
Überleben von Bakterienzellen nimmt.
In Versuchen im Hinblick auf Sicherheitsaspekte sind Fichtennadelharz oder 
Harzsalbe in Ames-Tests nicht mutagen und die 10%:ige Harzsalbe hat keine be-
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deutende reizende (irritative) Eigenschaft laut kontrollierten Hautreizungstests und 
Irritationstests. Bei zertifizierten in vitro Tests mit Fibroblastenzellkultur erwies 
sich die 10%:ige Harzsalbe als zytotoxisch.  
Gas-Flüssigkeits-Chromatographie (GLC) und Massenspektrometrie- Studien 
zeigten, daß Harz und Harzsalbe (Acetonextrakte) mindestens drei biologisch po-
tente Stoffgruppen enthalten: p-Cumarsäure, Harzsäuren und Lignane. Diese Stoffe 
treten insgesamt mit einer durchschnittlichen Konzentration von 300 mg/g in Harz 
(w/w) und 30 mg/g (w/w) in Harzsalbe auf. Zusätzlich enthält Harz Fettsäuren, 
Monoterpene, Flavonoide und Tannine, von denen keine Konzentrationsberech-
nungen durchgeführt wurden.
Einer der klinischen Studien ist eine randomisierte, vorausblickende Untersu-
chung, bei der die Wirksamkeit von Harzsalbenbehandlung über einen Zeitraum 
von 6 Monaten mit der Wirksamkeit von Hydrofaserverband (mit oder ohne Silber) 
an 37 Patienten mit schweren, Grad II-IV, Druckgeschwüren verglichen wurde. Bei 
diesem Versuch erwies sich die Harzsalbe sowohl laut Protokoll-, als auch laut ITT 
(intention-to-treat)- Analyse als deutlich wirksamer (P=0.003) bei der Verbesserung 
der Geschwürsheilung (sowohl im Hinblick auf die Heilungsrate pro Patient (N=23), 
als auch pro Geschwür (N=29)) als die Kontrollbehandlung. Alle Druckgeschwüre 
der Patienten (laut Protokollanalyse) in der Harzgruppe heilten, mit Ausnahme 
eines Geschwürs bei einem Patienten (94% (95%CI 84-100%)), wohingegen we-
niger als die Hälfte (36% (8-65%)) der Geschwüre in der Kontrollgruppe heilten. 
Harzsalbe verbesserte den Heilungsprozess von Geschwüren unabhängig davon, 
ob das Geschwür infiziert war oder nicht. 
Die andere klinische Studie war eine beobachtende und vorausblickende Un-
tersuchung zur Wirksamkeit und Anwendbarkeit der Harzsalbenbehandlung bei 
chronischen, komplizierten Operationswunden in einer Kohorte bestehend aus 
23 Patienten. Bei allen 23 Patienten heilte die Wunde durchschnittlich innerhalb 
von 43±24 Tagen ohne jegliche Nachteile. Bei der Harzsalbentherapie heilten die 
Wunden schrittweise (re-epithelisiert), im Durchschnitt 2 mm pro Tag. 
In den klinischen Studien (randomierte Studie und Observationsstudie; per 
protocol), die insgesamt 45 Patienten umschlossen, wies ein Patient (2%; 95%CI: 
0-5%) eine allergische Reaktion auf (allergische Kontaktdermatitis). Es wurden 
keine anderen Komplikationen oder Nebenwirkungen beobachtet. Die direkten 
Kosten für pharmazeutisches Material waren durchschnittlich 1,2 € ±0,5 € pro 
Tag pro Patient, welche mit der Harzsalbe behandelt wurden.
Die Studien zeigen, daß die Harzsalbe objektiv betrachtet effektiv, günstig und 
gefahrlos in der Behandlung von Hautwunden ist. Harz und die 10%:ige Harzsalbe 
sind gegen eine Vielzahl von Mikroorganismen antimikrobisch, aber der positive 
Einfluß der Salbe auf die Heilungsgeschwindigkeit der Wunde, muß auf andere 
Mechanismen zurückzuführen sein als auf die Antimikrobität alleine.
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11. APPENDICES
11.1 Appendix I.   
 descriptions of the terms commonly used in the present papers
Terms resin, rosin, colophony, pitch, etc. are widely used confusingly in the literature 
and in the labels of various natural or industrial products. The terminology is not 
fully established, and the terms are often used intermixed without definitions and, 
therefore, may cause misunderstandings. In the present context, the definitions are:
Resin: Resin is a natural hydrocarbon secretion of many plants, especially of 
coniferous trees like the spruce and the pine. The resin is a natural product and is 
a mixture of resin acids (e.g., abietic acid, hydroxyabietic acid) with other natural 
terpenic compounds and fatty acids. In the present papers, the term “resin” refers to 
the coniferous non-physiologic “callus” resin from the Norway spruce (Picea abies).
Rosin and colophony: Rosins are manufactured from the resin by fractional 
distillation to vaporize the volatile terpenes and terpenoids, resulting in products 
that are composed practically of only the resin acids. Thus, the rosins can be consi-
dered technical and chemical products originating from the natural resins or wood 
extracts (e.g., tall oil). Rosins may also be products that are mixtures or derivates 
of various chemically purified natural resin acids. Rosins are used in manufactu-
ring a wide range of different products, e.g. varnishes, adhesives, cosmetics, paints. 
Occasionally, the term colophony is used as a synonym for rosin. 
Resin acid: Resin acids (e.g.; dehydroabietic, levopimaric, pimaric, palustric, 
isopimaric, sandracopimaric, abietic acid and neoabietic acids) are specific tricyclic 
and diterpenic organic acids in both resins and rosins.  
Lignans: Lignans (e.g.; lariciresinol, pinoresinol and matairesinol) are, in addi-
tion to the resin acids, a group of ingredients of the natural non-physiologic callus 
resin. They do not exist in the technical rosins and oleoresins. Lignans are water 
soluble and are metabolized by enteric bacteria to enterolactone and enterodiol. 
Lignans have been used as food additives.
Coumaric acid (hydroxycinnamic acid; hydroxy derivate of cinnamic acid): 
A component in natural wood extracts. Coumaric acid is considered to have an-
tioxidative properties. Its exact biological role is unclear. Coumaric acid is found, 
besides in conifers, in different plants like carrots, tomatoes and garlic, or in wine 
and vinegar. 
Terpenes and terpenoids: Terpene hydrocarbons are derived biosynthe-
tically from the isoprene (C5H8) units. They form of a large group of dissimilar 
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compounds in the plant extracts, some of which are volatile, and some of which are 
not. When the terpenes are modified chemically (e.g., methyl groups are modified, 
or oxygen atoms are added) the resulting compounds are generally referred to as 
terpenoids. Some authors will also use the term terpene to include all terpenoids. 
Terpenes are classified by number of terpene units in the molecule. Diterpenes 
are composed of four isoprene units (molecular formula C20H32). The resin acids 
are nonvolatile diterpenes. Steroids and vitamin A are other examples of terpenes.
11.2 Appendix II.  
 Wound care products and dressings
In Finland there are six proprietary medicinal products available and authorized 
for the treatment of wounds and ulcers: 
• Products containing dexpanthenol as the effective agent. Dexpanthenol 
turns into panthenol in the skin and mucosal tissue. It is considered to 
have positive influence on re-epithelialization and collagen durability. 
 » Bepanthen (marketing authorization holder: Bayer)
 » Bepanthen (Orion)
 » Dexpanthenol (Ratiopharm)
• A product containing platelet-derived growth factor (PDGF) beclapermin. It 
is intended for the treatment of neuropathic and ischemic diabetic wounds 
extending into subcutaneous tissue. An increased risk of manifestation of 
malignancy has been observed in patients treated with beclapermin. 
 » Regranex (Janssen-Cilag)
• Product containing clostridiopeptidase A. Clostridiopeptidase A is only acti-
ve in a moist milieu, and as an enzymatic agent it is indicated for enzymatic 
debridement of necrotic wounds. 
 » Iruxol and Iruxol mono (Smith & Nephew)
Many types of dressings are available in Finland in 2012 for the wound care. 
The recommendations and properties are listed below, as presented by the manu-
facturers and as collected by Iivanainen and Seppänen (2011). It is noteworthy that 
most of the properties mentioned in the list have not been scientifically examined 
and are only the opinions of the commercial manufacturers.
Passive dressings
These dressings (gauzes) protect the wound and do not contain any active compo-
nents that might influence the wound healing. The occlusive gauzes can be air- or 
watertight and they provide a seal from the environment. 
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Interactive dressings
The interactive dressings contain properties considered to actively influence the 
wound healing processes. These dressings can be separated into different categories:
Dressings containing active carbon: The dressings remove bad odor from 
the wound and can be used, for example, in infected and malignant wounds.
Alginate dressings: The dressings contain brown alga that will change to a 
gel in contact with wound secretions. The dressings are considered to have auto-
lytic and haemostatic properties. They can be used in wounds with moderate or 
heavy exudation.
Silver dressings: The silver impregnated dressings have antimicrobial pro-
perties and recommended to be used in infected wounds. Silver has antimicrobial 
properties but is reported to induce antimicrobial resistance. 
Hydrofiber dressings: The dressings compose of natriumcarboxymethylcel-
lulose with a high absorption capacity. They can be used in wounds with moderate 
or heavy exudation. Hydrofiber dressings will change to a gel in contact with wound 
exudates. The dressings are considered to have autolytic properties.
Hydrophobic dressings: These are dressings with hydrophobic property. 
Microbes are considered to adhere to the dressing and are removed when the dres-
sing is changed.
Hydrogels: The hydrogels contain abundant water and the dressings mois-
turize the wound permitting autolytic debridement. 
Hydrocolloids: Hydrocolloid dressings moisturize the wound permitting au-
tolytic debridement. These dressings are not recommended to be used in infected 
wounds.
Polyurethan dressings: Polyurethan dressings are recommended in su-
perficial wounds like abrasions, burn wounds and surgical wounds. The dressings 
have no absorption capacity.
Zink dressings: Zink dressings are designed for venous leg ulcers below the 
compression bandages. Zink protects from excessive moisture.
Resin dressings: A salve with antibacterial, antifungal, and with debridement 
properties and recommended to be used in skin wounds when impregnated into an 
appropriate dressing, or by spreading the salve onto the wound directly and then 
covering the wound with an appropriate dressing or band. The salve enhances re-
epithelization.
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11.3 Appendix III.  
 microbial strains used in microbiological studies
